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CHAPTER ONE
Introduction to the B artonella and
Genetic M anipulation

I. THE BARTONELLA

A. INTRODUCTION
The bartonellae are a unique group of gram negative intracellular bacteria that
employ arthropod-mediated transmission and hemotrophy as common parasitic strategies.
Phylogenetically, recent taxonomic re-classifications have expanded the number of
Bartonella species from one, B. bacilliformis, to 11 species, based on sequence homology
and genetic relatedness. Five of these species are presently considered agents of emerging
infectious disease in humans (B. bacilliformis, B. clarridgeiae, B. elizabethae, B. henselae,
and B. quintana), and share pathologies of bacteremia, anemia, relapsing fever, and a
variety of angiomatous lesions (for recent reviews see references 7, 91, and 125). Human
morbidity and mortality have been associated with numerous manifestations of the
Bartonella, and are explained in detail below.
A considerable amount of data have been accumulated concerning the epidemiology
of the bartonellae. With the exception of B. bacilliformis, which is uniquely endemic to the
Andes Mountains of South America, there are apparently no geographic boundaries for the
remainder of the genus. Bartonellae have been isolated from a variety of sources including
cats, dogs, birds, fish, rodents, and even plants. Arthropod-mediated transmission is the
primary route of infection, and a diverse range of insect vectors including sandflies, mites,
lice, fleas, and ticks have been shown to harbor bartonellae. The combination of reservoir
and vector diversity, as well as reports of co-isolation of bartonellae with other human
pathogens, has lead to much discussion of the epidemic potential of this genus. A
1
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thorough summary of the hosts, reservoirs, and vectors is presented below.
It is noteworthy that there is a dearth of information concerning the pathogenesis
and epidemiology of the obscure pathogen B. bacilliformis. Probably due to higher levels
of morbidity and mortality, much more has been published (in English) pertaining to B .
henselae and B. quinlana. These former members of the Rochalimaea share many
characteristics with B. bacilliformis which will be mentioned below to provide a more
comprehensive understanding to the reader.

B. PHYLOGENY OF THE BARTONELLA
The type species of the Bartonella genus, B. bacilliformis(26), was originally
classified as belonging to the order Rickettsiales of the alpha Proteobacteriaand was the
only species in the family Bartonellaceae. Recent taxonomic reclassifications based on
sequence homology, DNA hybridization data and G+C content have removed the family
Bartonellaceae from the order Rickettsiales and placed it in the order Rhizobiaceae (27). In
addition, members of the family Rickettsiaceae belonging to the genera Rochalimaea
including R. quimana, R. vinsonii, R. elizabethae, and R. henselae were reassigned to the
family Bartonellaceae and subsequently the genus Rochalimaea was added to the group
(27). Finally, the genus Grahamella, which was a late addition to the family
Bartonellaceae, was unified with the Bartonella genus (21). All of these taxonomic
changes were proposed between 1993 and 1995, and have been corroborated by several
sources (19, 22, 26, 33, 40, 105, 120, 126-128, 137, 148, 172) included in this is the
high degree of sequence similarity between the B. bacilliformis flagellin sequence and
other fiagellins in the alpha Proteobacteria (135). Interestingly, the Bartonellaceae share
homology with mitochondrial and unidentified symbiont sequences.
If these taxonomic rearrangements are reminiscent of a daytime drama, please refer
to Figure 1, a phylogenetic tree derived from 16S DNA sequence alignments (Adapted

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

3

Figure 1. Phylogeny of the B arton ella. This phylogenetic tree was adopted from a
previous publication by M.F. Minnick in (124). Construction was achieved using 16S
rDNA sequences of the mentioned bacteria from GenBank, comparison of the sequences
was accomplished using Clustal software (PCGene 6.0; Intelligenetics).
Knuc is a measure of evolutionary distance. The phylogenetic relationships of several a proteobacteria as well as the prototypic y-Proteobacteria, Escherichia coli. Notice the
likeness between the plant pathogens {Agrobacterium tumefaciens and Rhizobium meliloti)
and the Bartonella. Four of the eleven species of Bartonella are provided here. For a
complete list refer to Figure 2. The species shown as listed from the top are Afipia felis
(originally suspected as the etiologic agent of cat-scratch disease), Agrobacterium
tumefaciens, Brucella abortus, Rhizobium meliloti, Bartonella bacilliformis, B.elizabethae,
B. henselae, B. quintana. Ehrlichia risticii, Rickettsia prowazekii, and E. coli.
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from (124). The dendrogram does not include several of the new Bartonella species, and
the reader is referred to Table 2 below for a complete listing of all of the species in the
Bartonella genus to date.

C. HISTORY AND EPIDEMIOLOGY OF THE B A R T O N E L L A

1. B . b a cillifo rm is.
The diseases caused by B. bacilliformis have been dated as early as pre-Columbian
times by anthropomorphic pottery depicting individuals with lesions representative of
verrugas (180); the cutaneous eruptions associated with the second phase of the disease.
Recent anthropological data has identified verrugas on a pre-Columbian Peruvian mummy,
apparently a human sacrifice, and used transmission electron microscopy (TEM) to show
bacilli with polar fiagella within the verruga representative of B. bacilliformis (3).
The cutaneous eruptions caused by B. bacilliformis and the eukaryotic pathogen
Leishmania viannia peruviana (or L. mexicana) were referred to in folklore by the natives
of South America as ‘Uta’, which was their name for the sandfly associated with both
diseases (72). The native terminology for the diseases has become more specific since that
time; ‘Uta’ has become synonymous with cutaneous leishmaniasis caused by Leishmania
viannia peruviana (2), and B. bacilliformis maladies are referred to as mal de Carridn.
Interestingly, these pathogens not only share similar clinical presentations (cutaneous
eruptions), but both L. viannia peruviana and B. bacilliformis share the unique geographic
endemicity of the Andes Mountain region of South America. It has been demonstrated that
over 60% of the asymptomatic population in this region is seropositive for B. bacilliformis
and 5-10% are active carriers of the infectious agent (89, 103). The primary reason for this
limited distribution is believed to be the habitat of the phlebotamine sandfly Lutzomyia
verrucarum that is the arthropod vector associated with both diseases.
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TABLE 1: Significant Moments in the History of the Bartonella

Year Event

Source(s)

1540 Pizarro's companions note ‘verrugas’ among the ‘conquistadors'

(53)

1630 First account of human bartonellosis

(71)

1764 First account of sandfly vector

(71)

1858 First description of anemic phase by Salazar

(53)

1870 first recorded major epidemic; Peru. -8000 fatalities

(178. 53)

1885 D. Carrion dies while demonstrating biphasic nature of the disease

(178)

1905 A.L. Barton first reports B. bacilliformis

(149. 178)

1915 Strong ctal. confirm biphasic nature of the disease

(178)

1915 Millions of soldiers suffer from Trench fever caused by B. quintana *

(143)

1926 Noguchi and Battistini demonstrate Koch’s postulates

(178)

1929 Noguchi and Shannon confirm Phlebotamine vector

(178)

1938 Second recorded major epidemic; Columbia. -4000 fatalities

(178)

1959 Peruvian outbreak. -200 deaths

(178)

1987 Peruvian outbreak. 14 deaths

(61)

1988 First report of bacillary angiomatosis; new R. henselae pathogenesis*

(104)

1993 Family Bartonellaceae placed in the order Rhizobiaceae

(27)

1993 Rochalimaea genera unified with genus Bartonella

(27)

1995 Genus Grahamella unified with genus Bartonella

(21)

* Indicates species of Bartonella other than B. bacilliformis.
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In 1929, the folklore of the natives was verified when Battistini, Noguchi and
Shannon identified Lutzomyia sandflies (formerly Phlebotomus) as the vector for B .
bacilliformis (73, 180). Lutzomyia lives in narrow valleys and cooler areas primarily
between the altitudes of 500-3000 meters above sea level in the Andes Mountain regions of
Peru, Columbia, and Equador (103). Several studies have implicated the female of the
species as the responsible vector, and that human infection takes place at night, when the
environmental temperatures are between 18°C and 20°C (71,73). Furthermore, studies
have demonstrated that the bacteria produce a massive proboscis and pharynx infection in
the sandfly (73) The male sandfly has not been associated with human blood meals (71,
73), but alternatively has been observed feeding on plants (personal communication, R.
Birtles, 1997).
The question of the B. bacilliformis reservoir is still ambiguous. Native folklore
has instigated several studies of euphorbiacous plants as a possible reservoir. In 1930,
Maldonado noted a connection between the ‘verruga zones’, or endemic areas, and these
euphorbiacous plants (71). In the same year, Weiss isolated organisms similar to B.
bacilliformis from the latex of these plants, and shortly thereafter, Mackehenie isolated and
cultured these organisms from the plant latex on three separate occasions and was able to
produce verruga-like nodules in chickens (71). These data led to a proclamation in 1935 by
Escomel to destroy the suspected plants, Jatrophamacranlhaand Jatrophabasiacantha (71).
In 1953, Herrer attempted to reproduce these results and also tried to grow B. bacilliformis
on the plant latex, without success (71). The frequency of disease incidence is directly
correlated with the rainy seasons (December-April), and is the time when these plants leaf,
corroborating the plant reservoir hypothesis (71). Considering the close phylogenetic
relationship that B. bacilliformis has with plant pathogens such as Rhizobium and
Agrobacterium (181), and the observation that the male Lutzomyia feeds on plants
(personal communication, R. Birtles, 1997), this hypothesis is firmly established. Finally,
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sandflies have been observed feeding on pigs, field mice, dogs, monkeys, chickens doves,
and plants, and interestingly are not attracted to lizards (72), (personal communication, R.
Birtles, 1997). Thus far, humans are the only widely accepted reservoir for B .
bacilliformis (70, 72).
With one unsubstantiated exception (182, 185), all documented cases of B.
bacilliformis infection have been associated with these geographic and vector restrictions.
New reports of an atypical manifestation of B. bacilliformis, presenting with cutaneous
eruptions in the absence of the primary anemic phase, have been causing some concern (2,
4). Amano et al. describe these atypical monophasic presentations as emerging in
previously disease-free lowland elevations (2,4). The authors suggest that since
Lutzomyia verrucarum has not been observed at this low altitude, a new strain of B .
bacilliformis or a unique species of Bartonella, with an alternative vector, may be the cause.
To provide a more comprehensive summary of the epidemiology of the Bartonella,
the remainder of this section will focus on other Bartonella species. Of the remaining
Bartonella that are pathogenic to humans, B. quintana and B. henselae have been associated
with the highest numbers of human morbidity and mortality.

2. B . qu in tan a .
B. quintana, the first identified Rochalimaea infection (90), caused over one
million cases of morbidity in military personnel during World War I (83,144). In recent
past there has been a resurgence of this disease in homeless persons, alcoholics and
intravenous drug users in inner-city populations (29, 36,44, 45, 83, 84, 142, 147, 167).
In contrast to B. bacilliformis, B. quintana apparently has no geographic restrictions, and
has been reported in France, England, Canada, Africa (29, 142), Seattle, Washington (84),
and Baltimore, Maryland (36).
In several of these case studies, there was a direct correlation between disease
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Table 2: The Bartonella Genus
Species

Human Disease

Vector

Source(s)

B. bacilliformis

Oroya Fever, Verruga peruana

Sandfly

(72. 79, 178)

B. quintana

Trench Fever, BA. endocarditis

Human body louse, fleas?

(175)

B. henselae

CSD. BA, endocarditis

Rea. Cat-scratch

(143. 93)

B. elizabethae

endocarditis

unknown

(37)

B. clarridgeiae

CSD

cat scratch

(94)

Species not vet associated with human disease
B. vinsonii

(184)

B. talpae. B .p ero m ysci. B. grahamii, B. taylorii, and B. doshiae

(21)
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frequency and alcoholism or drug use. The rate of infection, as well as the variety of
clinical pathologies reported in immunocompromised individuals, is significantly higher
than immunocompetent individuals, although infection does occur in immunocompetent
individuals (10,35). B. bacilliformis and B. quintana share two epidemiological features;
a single known reservoir, and a single reported vector. First, humans have been identified
as the only reservoir for B. quintana , and second, this species has been associated only
with a single vector, Pediculus humanus humanus, the human body louse (82, 83, 177) as
the sole vector for this species.

3. B. henselae.
To date, B. bacilliformis has caused more deaths than any other Bartonella, and B .
quintana is responsible for the highest numbers of human morbidity. Recently, however,
B. henselae has emerged as the predominant species causing a variety of clinical
pathologies in both immunocompetent and immunosupressed individuals. This organism
was originally identified in HIV-1 individuals presenting with cutaneous lesions similar to,
but distinct from, Kaposi’s sarcoma (34,40, 105), termed bacillary angiomatosis (BA)
(146). Shortly thereafter, B. henselae was recognized as the etiologic agent of cat-scratch
disease (CSD) (8,27, 144, 184). Although Afipia felis was originally thought to be the
etiologic agent of CSD, B. henselae is now accepted as the cause. In general, B. henselae
infection of healthy individuals results in CSD, whereas infection of the
immunocomprimised results in BA. Both syndromes are discussed in section E, below.
The epidemiology of B. henselae is unique in that the domestic cat, Felis
domesticus, has been positively identified as a relatively asymptomatic reservoir (70,87,
111, 172, 174). There is apparently no geographic restrictions of endemicity, for the
bacterium has been observed in cats throughout the world (32,70,87,99, 111, 190).
Approximately one third of all United States households own at least one cat,

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission .

11

corresponding to over 57 million pet cats in the U.S. alone (94).
The cat flea, Ctenocephalides felis (94), has been established as the arthropod
vector for B. henselae by experimental transmission from infected cats to specific pathogen
free cats (32), and by injection of live suspensions (64). Clinical symptoms of
experimental infection in the cat include fever, lethargy, and lymphadenopathy, which
dissipate quickly and a bacteremic state subsequently ensues for up to 32 weeks (64).
Interestingly, in the U.S. there is a direct correlation between cat flea prevalence, yearly
average temperature, and percent of seropositive cats (87). Finally, although B. henselae
has not been detected in dogs, Ctenocephalidesfelis has also been shown to infest dogs
(172).

4. Other Bartonella.
Very little is known regarding the epidemiology of the two remaining human
Bartonella pathogens, B. clarridgeiae, and B. elizabethae. B. clanidgeiae has been isolated
from cats independently (70), or as a co-infecting agent with B. henselae (65). B .
elizabethae has only been associated with human endocarditis (38) and CSD (33).
The other six described species of bartonellae have their roots in the former
Grahamella genera (20). Although not associated with human morbidity or mortality, they
have been observed in rodents, fish, mammals and birds (20), and are the cause of
pathologies in other mammals that resemble human maladies (25, 96, 186). There is also a
wide range of arthropod vectors associated with these remaining species including mites
(12), fleas (103) and ticks (77).
Finally, it is notable that different Bartonella species have been found together in
nature (65,77). A recent report that emphasizes this notion was the co-segregation of a
novel Bartonella species with both Borrelia burgdorferi and the hemotrophic parasite
Babesia microti (77). The diversity of reservoirs and vectors of the Bartonella combined
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with the notion of virulence-gene transfer with different Bartonella species as well as with
alternate pathogenic bacteria (B. burgdorferi) may extend the emergence of the Bartonella
for many years to come.

D.

PHYSICAL CHARACTERISTICS
The Bartonellae are small, gram negative, aerobic, pleiomorphic bacteria varying

between coccoid and bacilliform cellular morphologies. B. bacilliformis has a size of
approximately 13-3.0 pm long by 0.25-0.5 pm wide (26, 103, 175, 181). These
microorganisms are fastidious, facultative intracellular pathogens that are generally
cultivated between 30°C and 37°C in the presence of hemin or erythrocyte lysate, and
serum (118), and are oxidase negative, catalase positive, and non-fermentative (26). B.
bacilliformis exhibits two different colony morphologies, termed T1 and T2, that have
been shown to have differential degrees of erythrocyte adherence and interconvert upon
passage( 179).
Both B. bacilliformis (180) and B. clarridgeiae (33,95) constitutively express a tuft
of I-10 polar flagella filaments from one pole, which is termed a lophotrichous flagella. B .
henselae has also been shown to express flagella under certain growth conditions (personal
communication, K. Karem, 1997). The flagellum provides B. bacilliformis with a high
degree of motility (26, 115, 116, 164, 179), and is the virulence determinant that we
focused on in this dissertation. The 42 kDa (164) flagellin subunit of B. bacilliformis has
been identified as highly immunogenic (124). One report identifies 14 outer membrane
proteins (OMP’s) which range in size from 11.2 kDa to 75.3 kDa, and designates three of
these OMP’s, 31.5 kDa, 42 kDa and 45 kDa as highly immunogenic (124). Finally, the
LPS of B. bacilliformis has been shown to be a poor immunogen (124) but it does induce
hyper-reactivity in rabbits (130).
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The Bartonellae have an AT-rich genome; the type strain of B. bacilliformis has a
G+C content of approximately 40% (26), and B. quintana has been shown to have 38.6%
G+C (173). The B. bacilliformis chromosome is a single circular molecule of
approximately 1,600 kbp (104). Bacteriophage-like particles (BLP) have been identified in
both B. bacilliformis (175) and B. henselae(5). The BLP’s evidently package random 14kbp segments of double-stranded DNA into their acid-resistant protein coats (5,
24)(personal communication, M.F. Minnick 1998). Neither B. quintana, B. elizabethae,
nor B. vinsonii has demonstrated this 14 kbp extrachromosomal segment, and is thus
thought to be lacking BLP’s (5). It is interesting that a major protein of this BLP coat,
Pap31, shares 68% sequence similarity with an outer membrane protein of Rhizobium
leguminosa, a plant-associated bacterium (24). In addition to BLP’s, B. quintana B.
henselae, and B. bacilliformis have been shown to form membrane blebs of unknown
function (28)(personal communication, M.F. Minnick 1998).

E. PATHOGENESIS
In general, the Bartonella are the only hemotrophic bacteria infectious to humans
(153). Hemotrophy is the parasitism of erythrocytes. There are several human
hemotrophic maladies which arise from protozoa (plasmodia, babesia, theileria, and
trypanosomiasis) ( 1CB), and several hemotrophic bacteria which have been isolated from
other mammals (Eperythrozoa, Anaplasmataceae, haemobartonellae) (43, 103, 153). It is
interesting that all hemotrophic bacteria identified thus far are arthropod borne, and have a
variety of vectors including ticks, sandflies, fleas, and lice (103).
Most of the diseases caused by Bartonella have three common themes;
hemotrophy, infection of endothelial tissue, and immunosuppression. The hemotrophy can
range from acute bacteremia to the severe hemolytic anemia as manifest in the primary
phase of B. bacilliformis infection. Several sequelae result from cutaneous or sub

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

14

cutaneous endothelial cell invasion by the bartonellae in immunocompetent individuals.
These include the maculopapular rash associated with classical B. quintana infection, the
cutaneous granulomatous lesions of cat-scratch disease resulting from B. henselae, and the
angiomatous eruptions caused by B. bacilHformis. In general, infections in
immunosupressed individuals can result in a variety of atypical consequences in which the
bartonellae can invade endothelial cells throughout the body causing angiomatous lesions
from the liver to the brain. The bartonellae are the only infectious agents reported to cause
angiomatous lesions (37). In fact, immunosuppression appears to be induced by these
organisms and often results in secondary opportunistic infections that complicate diagnosis
and treatment.
Clinical manifestations in both immunocompetent and immunosupressed
individuals are explained in detail below. For further reading, refer to two excellent
reviews of the pathogenesis of Bartonella infections by Minnick (125) and Koehler (91).

1. Carrion’s disease: Oroya Fever and Verruga peruana
B. bacilliformis is the etiologic agent of a biphasic disease in which the primary (or
hematic) phase is associated with fever and anemia, and the second (or tissue) phase is one
in which the organism parasitizes endothelial cells resulting in vascular lesions. The term
Carridn’s disease is used in reference to both the primary phase as well as the entire
biphasic syndrome. Oroya fever is commonly used to describe the first phase, and is
characterized by an acute syndrome of fever, malaise, and a severe febrile hemolytic anemia
(54, 150, 180). Humans present with this acute hematic phase of the disease within 2-3
weeks following inoculation of bartonellae into the bloodstream by the bite of a nocturnal
sandfly, Lutzomyia verrucarum (62). During this hematic phase the bacterium invades
nearly every erythrocyte in the blood and subsequently reduces the hematocrit by nearly
80% (81). The anemia of this phase of the disease is responsible for the high (40-80%)
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mortality rate in the absence of antibiotic therapy (62, 103), and has killed over 10,000
humans in recorded time (62, 180), and affected many others (62, 108, 112). Reports
have stated that this anemia is a result of the reticuloendothelial system (RES) attempting to
eliminate the bacteria by phagocytosis (143,150). Furthermore, Dealler, et al. state that B .
bacilliformis induces a severe immunosuppression and that this is the cause of most of the
deaths (40). Bacteremia is often a manifestation of infection with several of the Bartonella,
as will be explained below.
The chronic secondary phase of the disease, termed verruga peruana (Peruvian
warts), develops weeks to months after infection and is characterized by blood-filled
cutaneous eruptions on the extremities (62). During this phase, B. bacilliformis invades
vascular endothelial cells, the epithelium lining the blood vessels (53,54, 115), and
presents with hemangiomas on the face and extremities, immunosuppression,
hepatosplenomegaly and lymphadenopathy (54). A novel approach to the pathogenesis of
this phase was proposed by Recavarren and Lumbreras in which the human body drives
the bacteria to the skin, and the verrucous tissue develops to eliminate the Bartonella during
this second phase (143). The majority of data support the contrasting notion, in which the
bacteria induce the angiomatous lesions. For example, Garcia et al. demonstrated that B .
bacilliformis possess a factor larger than 12-14 kDa which induces the release of tissue
plasminogen activator (t-PA), an angiogenic metabolite, from endothelial cells (52).
Furthermore, B. bacilliformis extracts were shown to stimulate formation of new blood
vessels in in vivo experiments with rats (52). Endothelial cell invasion is a common
pathogenic technique used by a number of the Bartonellae.

2. Trench Fever
Bartonella (formerly Rochalimaea) quinlana caused morbidity in millions of soldiers
suffering during World War I (83, 144, 147) and has been reemerging primarily in inner

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited without p erm ission.

16

city homeless populations during the last 15 years. (29, 36,44, 45, 83, 84, 142, 147,
167). The classical disease caused by B. quintana, called Trench Fever, Shinbone Fever,
or Five Day Fever presents with relapsing fever, malaise, bone pain, chills, headache and a
maculopapular rash (177) after inoculation by the human body louse Pediculus humanus
humanus (82,83). In immunocompetent individuals this disease is usually self-resolving,
and symptoms can even be so mild that they are not recognized.
Although it was originally reported that#, quintana did not invade endothelium in
either the louse gut (82) or human tissue (13), it has been recently demonstrated that B .
quintana does invade endothelium, consistent with the other Bartonella (28). B. quintana
has been associated with a number of unusual clinical presentations in both
immunocompetent and immunosupressed individuals including endocarditis and a variety
of bacillary angiomatosis sequelae. These maladies will be discussed according to specific
disease below.

3.

Cat Scratch Disease (CSD)

Next to Trench Fever, Cat-scratch disease is the Bartonella infection which has
gained the most notoriety in the recent past (likely due to Ted Neugent’s rendition of “Cat
Scratch Fever”). Cat-scratch disease is a result of either B. henselae infection (15, 42, 69,
190) or B. clarridgeiae infection (33). The disease states range from an asymptomatic or a
self-resolving cutaneous granulomatous lesion (15,42, 69, 190), to a variety of serious
sequelae such as endocarditis and bacillary angiomatosis (below). The latter of the two
disease states usually occurs in children and immunosupressed individuals as a result of B .
henselae (or B. quintana) infection and subsequent bacteremia. Both endocarditis and
bacillary angiomatosis are explained below.
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4.

Endocarditis

Endocarditis is characterized by various alterations of the endocardium including
exudative, ulcerative, proliferative, and vegetative lesions and is most often associated with
a heart valve. A variety of infectious agents are known to cause endocarditis including
Staphylococcus, Sreptococcus, Rickettsia, Mycobacterium, and various mycotic agents,
which makes diagnosis a challenge. Bartonella endocarditis is most often associated with
B. henselae infection (46,79, 142), but has also been demonstrated resulting from B .
elizabethae (38), and B. quintana (44,86, 142). This disease most often presents in
alcoholics (86) or immunosupressed individuals, but has also been demonstrated in
immunocompetent adults (79). In addition, a report of dog endocarditis was diagnosed as
B. vinsonii (25).

5.

Bacillary Angiomatosis (BA)

Angiogenesis is a complicated process that results in the formation of new blood
vessels (90), and is often associated with cancerous tumors. Cutaneous presentation of
bacillary angiomatosis (BA) clinically resembles Kaposi’s sarcoma and was thus associated
with this early manifestation of HIV-1 infection (34). It was noticed at this time that these
epithelioid vascular proliferations clinically resemble the cutaneous eruptions called verruga
peruana of B. bacilliformis infection (40,105). Further investigation revealed histological
evidence that BA was distinct from Kaposi’s sarcoma having an epithelioid hemangioma
appearance (34).
Bacillary angiomatosis, a ‘bacilliform-induced angiomatous lesion’, is characterized
by nodular, cutaneous, visceral, or lymphatic lesions and has vascular channels lined with
cuboidal epithelium (37,144, 146). It was demonstrated that endothelial cell proliferation
and migration are remarkably stimulated in the presence of B. henselae and B. quintana,
and that fibroblast cells are unaffected (37). Furthermore, a trypsin-sensitive factor which
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is either a cell wall component or a very heavy intracellular molecule was identified with
this proliferation and migration activity (37).
The infection of B. quintana and B. henselae has only been reported to occur
from cat-scratches or bites, flea to human transmission has not been documented, but has
been hypothesized (94). After infection, the sequelae in immunocompetent hosts is usually
asymptomatic or CSD ensues and is self-resolving. In children and immunosupressed
adults, a variety of maladies can occur, ranging from cutaneous BA (10,34, 105), to
bacteremia and migration throughout the body. Reports of bacteremia (144,166),
granulomatous hepatitis (106), peliosis hepatis (55, 141), osseous lesions (93),
encephalitis (169), status epilepticus and coma (67), psychiatric symptoms (11),
pulmonary nodules (30), intra-abdominal mass and gastrointestinal hemorrhage (92),
pyogenic granuloma (10), polyadenopathy and splenomegaly (10), neuroretinitis (188),
aseptic meningitis (188), lymphadenitis (188), brain lesions and CNS infection (140),
seizure (154), prolonged fever and fever of unknown origin (FUO) (85), and
hypercalcemia (23) have been associated with either B. henselae or B. quintana.

F. VIRULENCE DETERMINANTS
The pathogenicity of an organism is defined as it’s ability to cause disease. The
virulence determinants, also called virulence factors, are the tools or mechanisms that an
organism uses in pathogenesis. To be pathogenic, Bartonellae must first be able to survive
the extreme disparate environments of arthropod vector and reservoir. Second, either by a
specifically designed mechanism or a serendipitous circumstance of natural existence, the
bacteria then manifest their pathogenicity on the host Methods of colonization, nutrient
acquisition, temperature acclimation, serum resistance, immune evasion, erythrocyte and
endothelial cell invasion, and angiogenesis are presently included in the pathogenesis of
these bacteria.
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The determinants utilized by Bartonella during pathogenesis, or virulence factors,
are poorly understood. Much of the research to date has focused on mechanisms of host
cell interactions with erythrocytes (14, 132, 164) and endothelial cells (28,37,52,53,90).
Reports concerning adhesion and invasion implicate three main virulence determinants; the
flagella (14,164), the deformin protein (116,189), and the IalA and IalB proteins encoded
by the invasion-associated locus, ialAB (132). In addition, reports of a hemolysin (129),
heme-binding protein (personal communication, M.F. Minnick, 1998), putative fimbriae
(121), bundle-forming pili (BFP) (114), heat shock protein (122), an angiogenic factor
(37,52), and a unique blebbing surface appendage (28) are included in the possible
virulence factors that are involved in host cell invasion.
Despite these studies, the mechanism by which Bartonella gain entry into
erythrocytes is unknown. The working model of B. bacilliformis erythrocyte invasion is
termed ‘forced endocytosis’. Interaction and adhesion with the erythrocyte surface may be
influenced by the following structures: flagella (164), filament A (121), and BFP (114).
Subsequently, the activity of three virulence factors, IaiA/IalB (132), deformin (116,189),
and the flagella (14, 164), propagate erythrocyte invasiveness by separate mechanisms and
are explained below.
Conversely, invasion of endothelial cells may involve induced endocytosis.
Erythrocytes are not capable of endocytosis (116) whereas endothelial cells can be
stimulated to (de)polymerize actin and perform endocytosis. Thus, endothelial cell
invasion may utilize a separate mechanism. One finding that supports this notion is a blebassociated surface appendage (28) that was reported to induce rapid endothelial cell
engulfment of B. quintana (invasion within one minute). This report contradicts early data
concerning B. quintana invasion, where it was previously thought to remain epicellular
(13, 98). Although blebs have been seen in association with B. bacilliformis, their
relationship to surface appendages and endothelial cell engulfment is unknown.
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Interactions of B. bacilliformis with endothelial cells are followed by a rapid invasion
(within one hour) (53), a reduction of invasion with endothelial cells preexposed to
cytochalasin D (115) suggests that micFofilament formation is required for invasion of
endothelial cells. These data suggest that the Bartonella use a mechanism of induced
phagocytosis to enter endothelial cells.

1.

Adhesion to Host Cell: Flagella, BFP, filA, and a blebbing
surface appendage.

After the bacterium is introduced into the host following arthropod inoculation or
cat-scratch, it is hypothesized to form a close contact, or adhere, to erythrocytes and/or
endothelial cells. Three membrane localized appendages have been implicated in the
process of B. bacilliformis adherence to erythrocytes; the flagella (164,179), bundleforming pili (BFP) (13, 114), and filament A protein (121).
In addition, adherence of B. bacilliformis is reduced after treatment of the
erythrocyte with a - or (3-glucosidase (catalyzes hydrolysis of terminal (3-glucose residues
from glycosides), and is stimulated after treatment of the erythrocyte with pronase or
subtilisin (proteolytic enzymes)( 179). These observations suggest that B. bacilliformis
adheres to a glycolipid moiety on the erythrocyte surface (179).

a. The Flagella.
The data presented in chapter three suggest that the B. bacilliformis flagella is
required for full host cell adherence capacity. Thus, the flagella may provide a motive force
and thereby permit other surface appendages (such as fimbriae or pili) to form a more
intimate bond with the host cell surface receptor(s). Conversely, the flagellum itself could
be involved with the host cell receptor directly. The data reported by Scherer et al. also
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suggest that the flagella may be involved in adhesion to the erythrocyte surface, for
association rates are decreased in the presence of anti-flagellin antiserum (164).

b. BFP
Fimbriae and pili are cell surface appendages and are virulence factors associated
with cellular adherence and colonization by a number of pathogenic bacteria. B. henselae
possess an appendage that phenotypically resembles type 4 pili (13). Also characteristic of
bacteria that possess type 4 pili, B. bacilHformis and B. henselae have demonstrated
autoagglutination, in which the bacteria clump in groups of 5 to 100’s (13, 114). When
subjected to specific purification strategies, the pili autoaggregate to form bundles, and are
hence called bundle forming pili (BFP), ranging from 50 to 600 nm in diameter (114).
These BFP were found to be resistant to treatment with 0.1% SDS and do not migrate into
SDS-PAGE gels (114). To date, this putative adhesion virulence determinant is
uncharacterized.

c. FilA
Recently, a gene located upstream of the ialA/ialB locus (described in 3, below)
was sequenced and shown to have a 1,200-bp open reading frame that shares sequence
homology with several filamentous proteins including the Ml protein of Streptococcus
pyogenes (121). The M l protein has been demonstrated to be involved in the adherence to
and invasion of host cells of Streptococcus pyogenes (121). Due to it’s filamentous nature,
the gene was named JilA and encodes a protein, FilA, with a predicted molecular mass of
approximately 47 kDa (121). Further sequence analysis indicates that the predicted protein
has a typical secretory sequence, a potential hydrophobic anchor, and a leucine-rich
composition (121). These data coupled with the similarity to M l protein suggest that this
predicted protein may be surface localized and may be involved in host cell attachment
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Further analysis of this putative adhesin has been hampered by the inability to clone the
gene in E. coli presumably due to toxic effects of the gene (personal communication,
M.F.Minnick, 1998).

d.

Blebbing surface appendage.

As was stated above, a blebbing surface appendage similar to those described for
Salmonella typhimurium (57) and Rickettsia conorii (170) has been described for B .
quintana and B. henselae (28). The blebs were apparently formed by cell wall
modifications and were only expressed by bacteria that had not achieved adherence (28).
Bacteria that had made contact with the endothelial cell surface induced host cell membrane
ruffles and engulfment were observed within one minute of cellular contact (28). These
tubular or vesicle-like structures are apparently involved in endothelial cell invasion of B .
quintana and B. henselae, and thus may also be utilized by B. bacilliformis. The finding of
reduced B. bacilliformis invasion of endothelial cells pretreated with cytochalasin D (115)
supports the hypothesis of microfilament-assisted invasion, or ‘induced phagocytosis’.

2.

Invasion of Host Cell: Flagella, ia lA lB , and Deformin

a.

The Flagella.

The lophotrichous flagella of B. bacilliformis and the high degree of motility that it
imparts has been implicated as a virulence determinant in several reports (14, 103,116,
164). In addition, B. clarridgeiae, an etiologic agent of cat scratch disease, has also been
reported as possessing a lophotrichous flagella (95). A dendrogram analysis of several
flagellin sequences demonstrated that the B. bacilliformis Ha is most similar to flagella
from Azospirillum brasilense, Rhizobium meliloti, Agrobacterium tumefaciens, and
Caulobactercrescentus, forming a cluster distinct from other flagellins (135). The mutation
data generated in this study suggest that the B. bacilliformis flagellar filament is composed
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of multiple polypeptide subunits of 42 kDa encoded by a single flagellin gene, fla (chapter
three), whereas many bacteria possess multi-subunit flagella.
Flagellum-mediated motility is a common strategy used by many pathogenic
bacteria to colonize or gain access to host tissues or cells (139). Aflagellated or
motility-impaired strains have decreased pathogenicity in numerous bacteria because of
impaired colonization, adherence, or invasion, or by an uncharacterized method. Examples
includeBorrelia burgdorferi (161), Campylobacterjejuni (60), Proteus mirabilis (134),
Serpulina hyodysenteriae{ 158), Agrobacterium tumefaciens (31), Vibrio anguillarum
(138), Vibrio cholerae (152), Salmonella typhi (63), and Helicobacterpylori (48). Several
reports have implicated uncharacterized motility-impaired B. bacilliformis as having a
reduced pathogenicity (14, 116, 179). Namarski optics demonstrated that B. bacilliformis
use a boring or twisting motion that is accompanied by a remarkable deformation of the
erythrocyte surface (14). Scherer et al. were able to demonstrate that both erythrocyte
invasion and association were decreased by treating the pathogen with anti-flagellin
antiserum (164). Motile cultures of B. bacilliformis have been shown to have a higher rate
of attachment and entry into erythrocytes (14, 116). Lastly, inactivation of proton motive
force (N-ethylmaleimide) or respiration (KCN) significantly reduces binding of the
bacterium to erythrocytes indicating that adhesion is energy-dependent (179). The flagella
of B. bacilliformis is undoubtedly driven by a proton motive force (58, 110).
These findings strongly suggest that a forced endocytosis entry into erythrocytes
requires flagellar-mediated motility. The data presented in chapter four suggests that the
flagellum is required for adhesion to human erythrocytes. Molecular Koch’s postulates
(49) were applied to the flagella of B. bacilliformis by first constructing the flagellin minus
mutant and a cognate complemented strain. The mutants were constructed by site-directed
mutagenesis using a suicide plasmid, and the transcomplementation was accomplished by
introduction of the wild-type flagellin gene on a replicative plasmid using
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electrotransformation. These strains represent the first site-specific mutant and first
transcomplement of any Bartonella. These data and a phenotypic analysis of the mutant
and transcomplemented strains are presented in Chapter Three. A virulence assay was then
developed and used to determine the virulence potential of the flagellin gene. In the data
presented in chapter three of this work we demonstrate that the flagellum is required for
wild-type rates of adhesion to human erythrocytes. This experiment is the first
demonstration of molecular Koch’s postulates for any of the Bartonella.

b.

Invasion Associated Locus: IalA and IalB.

Attempts to identify determinants of virulence can be accomplished in several ways.
In an elegant set of experiments performed by Mitchell and Minnick, the first virulence
related gene of any Bartonella was identified (132). In this study, a 1,469-bp BamHl
fragment of B. bacilliformis chromosomal DNA was found to confer an erythrocyte
invasive phenotype on minimally invasive strains of E. coli (132). Further cloning and
sequence analysis identified a two-gene ‘invasion associated locus’ (ial) that was
responsible for the invasive phenotype. Both of the genes, termed ialA and ialB, were
found to be necessary for the invasive phenotype in E. coli (132). Recently, IalB was
localized to the surface of B. bacilliformis by indirect immunofluorescence microscopy
(personal communication, S. Coleman, 1998). Finally, ialB was site-specifically
mutagenized utilizing the system developed and described in this dissertation (personal
communication, S. Coleman, 1998). Virulence data concerning this second site-directed
B. bacilliformis mutant are currently in progress.

c.

Deformin

An extracellular protein termed deformin is generated by B. bacilliformis grown in
a tryptone based medium and produces deep invaginations within erythrocyte membranes
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(116, 189). Deformin consists of a dimer having an apparent native molecular weight of
130 kDa (116). These trenches and invaginations are more apparent in trypsin-treated
erythrocytes, and the activity can be inactivated by protease treatment or a brief heat
exposure of 70°C (116). Interestingly, pretreatment of the erythrocytes with phospholipase
D produces deformin-resistant cells. This finding is consistent with the reduced adherence
of B. bacilliformis after treatment of the erythrocyte with a - or 0-glucosidase (179).
Scanning electron micrographs of deformin-treated erythrocytes show marked
trenches, indentations and invaginations on the surface of the cells (189). By using
Nomarski optics, B. bacilliformis was observed swimming into these induced trenches
with a corkscrew-like motion and were able to gain entry into the erythrocyte and that
non-motile bacteria never gained entry (14,116). The data concerning this virulence
determinant strongly support the current model of forced endocytosis.

3.

Angiogenic Factor:

To date, the Bartonella are the only infectious agents associated with angiomatous
lesions (37). As explained above, a factor is present in B. bacilliformis extracts that
induces the release of tissue plasminogen activator (t-PA) from endothelial cells and is able
to stimulate cellular proliferation of endothelial cells (52). This heat-sensitive factor is
larger then 14 kDa and was shown to stimulate formation of new blood vessels in vivo
(52). In another study, extracts of B. henselae and B. bacilliformis contained a
trypsin-sensitive factor that induced the proliferation and migration of endothelial cells, but
not fibroblast cells (37). This factor was established as either a cell wall component or a
very heavy intracellular molecule and, interestingly, activity was not apparent in B.
quintana extracts. These data support a pathogenic mechanism for the bacteria analogous
to tumor formation, whereby an endothelial cell site is colonized and subsequently direct
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nutrients to itself by the formation of new blood vessels.
The induction of t-PA release in endothelial cells by a Bartonella factor can have an
alternative interpretation. t-PA converts plasminogen to its activated form, plasmin.
Plasmin is a peptidase that dissolves thrombin, or clots, in the bloodstream. Streptokinase
is a plasmin analogue produced by (5-hemolytic streptococcus and is utilized by the
organism as a spreading factor during infection. These data taken together suggest that the
factor released by B. bacilliformis may indirectly reduce intravascular clotting (and thus
keep the host alive), as well as act as a spreading factor during infection.

4. Immune Evasion Factors and Strategies.
The hemotrophic propensity of the BartoneUa require that they have a mechanism
for dealing with immune recognition and destruction. Two in vitro experiments testing
humoral immunity demonstrated species-specific results. First, it was shown that human
non-immune sera killed more than 99.5% of 107 B. henselae after 2 hours, by classical
and alternate forms of complement fixation as well as phagocytosis (157). In contrast,
experiments with B. quintana demonstrate that it is complement-resistant (117). This
disparity between the humoral immunity of Bartonella species as well as the factorfs)
involved still remains to be explained.
An obvious mechanism of immune evasion is intracellular invasion and survival.
This also includes the rapid induced phagocytosis demonstrated by B. quintana (28). In
this in vitro study it was shown that the bacterium is engulfed by the endothelial cell in less
than one minute. The recurring ‘five day’ fever associated with B. quintana infection
suggests that cell surface modulation may play a part in immune evasion. Finally, the blebs
may be involved in immune avoidance. It was mentioned by Brouqui and Raoult that
Borrelia uses blebs as a form of immune evasion, and that Bartonella may do the same
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(2 8 ).

5.

Stress Response Factors

Bacterial stress response factors include a group of proteins referred to as GroEL,
GroES, DnaK, and HtrA (6). The temperature extremes of host (37°C) and vector (25°C)
require that the BartoneUa retain mechanisms for survival in these environments. B .
henselae and B. quintana have at least five heat shock related proteins ranging from 10
kDa to 70 kDa (66). Anderson etal. have putatively identified a 62 kDa immunogenic
protein in B. henselae that has sequence similarity to E. coli HtrA (6). The HtrA protein
is required by E. coli for growth at elevated temperatures. Finally, Minnick demonstrated
by single dimension SDS-PAGE that B. bacilliformis contains seven heat shock proteins
ranging in size from 17.6 kDa to 66.5 kDa when heated to 3T C for 40 minutes (122).
When applied to a two dimensional SDS-PAGE the same preparation revealed 23 heat
shock proteins (122). It is interesting that in vitro growth of B. bacilliformis is most rapid
at 30°C, whereas the bacteria barely survive even short exposures in vitro at 37°C.

6. Hemln Binding Factor:
The Bartonella are fastidious organisms that require a red blood cell lysate or hemin
supplemented medium for survival and growth in vitro (118). In addition, their
hemotrophic lifestyle suggests that a factor(s) may be involved in sequestration of hemin.
To begin to answer this question, a B. quintana genomic library was made in the low-copy
plasmid pACYC (personal communication, M.F. Minnick, 1998). Transformation of this
library into E. coli, followed by selection on LB+0.5% hemin isolated several
reddish-brown recombinants. Interestingly, sequence analysis of the inserts of one of
these recombinants suggests it is homologous to the virulence locus described previously
for B. bacilliformis (118, 121, 131-133) (personal communication, M.F. Minnick, 1998).
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G.

DIAGNOSIS, TREATMENT, and PREVENTION
1.

Diagnosis.

The lesions produced by B. bacilliformis (verruga peruana), B. henselae (BA), and
B. quintana are clinically indistinguishable from each other yet form unique cutaneous
angiomatous eruptions. Due to the varied presentations of bacillary angiomatosis, clinical
diagnosis can often be confused with salmonellosis, toxoplasmosis, tularemia, brucellosis,
histoplasmosis, Q-fever, coccidiomycosis, amoebiasis, Epstein-Barr virus, tuberculosis,
tetanus, syphilis, toxocariasis, rocky mountain spotted fever, chlamydia, and leptospirosis
(106), ehrlichiosis (166), malaria (155), UTI and osteomyelitis (85). In addition,
Bartonella infections that produce endocarditis can be confused with Staphylococcus,
Streptococcus, Rickettsia, Mycobacterium, and various mycotic agents. To further
complicate diagnosis, B. quintana infection was produced in a patient in the absence of
seroreactivity (45).
These inherent diagnosis complications as well as the slow and fastidious nature of
in vitro culture provide the impetus towards the development of a specific method for
clinical identification. PCR techniques using amplimers directed to unique targets have
been used successfully to diagnose Bartonella infections (8, 86, 88, 108, 136, 156), and
differentiate between Bartonella species (123, 160).

2. Treatment.
Although the bartonellae are highly susceptible to even low levels of antibiotics
(113), intracellular survival and opportunistic infections often require rigorous
antimicrobial treatment. A variety of antimicrobial agents have been used successfully to
treat different Bartonella infections including chloramphenicol (2,180), doxycycline (30),
erythromycin (141), gentamicin (45), (J-lactarns (180), streptomycin plus tetracycline (2,
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180), and aminoglycosides (180). Finally, enrofloxacin and doxycycline was successfully
used for treatment of B. henselae or B. clarridgeiae in cats (97).

3. Prevention.
In Chapter Three of this work we satisfy molecular Koch’s postulates with the
flagella of B. bacilliformis. This is the first demonstration of Koch’s molecular postulates
for any of the Bartonella ox Rickettsial organisms. The data indicate that the flagellum is
required for adhesion to erythrocytes. This suggests that a subunit vaccine incorporating
flagellin could be an effective means of vaccination. Variable expression of the flagella is
of course an argument concerning this notion. Overall, the significance of the development
of this system of genetic manipulation relates directly to determination of virulence
mechanisms and thus to vaccine production.
A vaccine has been made to protect cats from Bartonella infection. A B. henselae
vaccine for cats has been produce by Heska Corporation (personal communication, K.
Karem, 1997) developed for pet kittens of AIDS patients. No data is available on the
efficacy of this vaccine.
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II.

GENETIC MANIPULATION

A. Introduction and Background
The ability to genetically manipulate an organism is required for an accurate
molecular determination of virulence factors. In vivo genetic manipulation of a bacterium
generally consists of two fundamental techniques: plasmid transformation and mutagenesis.
These techniques utilize constructs consisting of supercoiled plasmids or linear fragments
of DNA that possess genetic elements specific to the genetic manipulation desired, and are
explained in detail below. The introduction of these DNA constructs into the bacterium can
be accomplished by natural (conjugation and transduction) or artificial (electroporation or
chemical) methods. In this study, we used electroporation to introduce a variety of
plasmids (both replicative and non-replicative) and linear DNA fragments, and were able to
demonstrate both plasmid transformation and site-directed mutagenesis.
Plasmid transformation is the introduction of a supercoiled plasmid harboring an
origin of replication that is recognized by the replicational machinery of the bacterium and is
subsequently maintained as an extrachromasomal fragment of DNA. Random mutagenesis
is a group of methods (chemical, UV-light, transposon) designed to generate nonspecific
mutations that are subsequently isolated by phenotype or biochemical means. Site-specific
mutagenesis is the introduction of mutations into specific genomic loci, for which there are
two techniques, replacement recombination and insertional recombination. Chapter Three
of this work describes the first characterized mutant of any Bartonella generated by
site-specific mutagenesis. Also mentioned in this section is natural mutant isolation, which
was used in Chapter Four of this work to isolate the first characterized natural antibiotic
resistant mutant Each of these techniques are explained in detail below.
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Figure 2.

Depictions of three strategies o f genetic manipulation.

A . Plasmid transformation is the introduction of a plasmid or cosmid harboring an origin
of replication (r) that is recognized by the replicational machinery of the cell. Origins used
in B. bacilliformis are RK2 (pEST) and REP (pBBRlMCS).
B . Insertional recombination occurs when a suicide plasmid (also referred to as an O-type
gene targeting construct) recombines a single time with its cognate target In this case, the
origin of replication (r •) is not recognized, and thus the plasmid is termed a suicide
plasmid. The entire construct is integrated into the chromosome by homologous
recombination, both inactivating the targeted gene and inserting an antibiotic resistance
cassette for selection. This strategy is employed in specific aim 2 and was utilized to
demonstrate site-specific inactivation of the flagellin gene (chapter 3). C . Replacement
recombination utilizes a linear fragment of DNA (also referred to as a Q-type gene targeting
construct), inherently incapable of extrachromosomal replication. A double cross over
event can replace either a few bases (specific aim 3) or disrupt the targeted gene (specific
aim 2).
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1.

Plasmid Transformation
The term plasmid transformation illustrates the event in which a plasmid harboring

a recognizable origin of replication is introduced into the organism resulting in the
maintenance of extrachromosomal DNA and synchronous marker expression. Thus,
replicative plasmids enable introduction and maintenance of genes into an organism as
extrachromosomal elements.
Shuttle vectors are a very useful tool of genetic engineering and genetic
manipulation and were used in this research for transcomplementation of the flagellin
mutant (Chapter Three), and introduction of the flagellin-promoted green fluorescent
protein (Chapter Five). Plasmids were also used to manipulate the flagellin gene in
targeting constructs (Chapter Two) and to clone and express gyrB (Chapter Four).
Maintenance of shuttle vectors usually requires constant presence of the antibiotic
corresponding to the resistance gene on the plasmid. In the course of this study, we
determined that the most consistent replicon for high transformation efficiencies in B .
bacilliformis was the broad-host-range vector pBBRlMCS and its derivatives, which
contain the REP origin of replication (100,101). Further, we demonstrate that this vector
is a suitable shuttle vector for genetic experiments involving Bartonella species and E. coli.
Reschke etal. were the first to demonstrate plasmid transformation in Bartonella
(formerly Rochalimaea) quintana by electrotransformation of the cosmid pEST (149).
Subsequently, Grasseschi and Minnick were the first to demonstrate plasmid
transformation in B. bacilliformis and it was reported that B. bacilliformis recognized the
RK2 origin of replication but did not recognize pMBl, CoIEl, or F origins (61). In this
study, the plasmid pEST was introduced into high passage B. bacilliformis by
electroporation, and high transformation efficiencies were reported (61). After numerous
attempts to repeat this experiment with my own hands were futile, the host strain used by
Grasseschi and Minnick was suspect for the high transformation efficiencies. To test this
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hypothesis, extant stocks of B. bacilliformis containing pEST were cultured and
subsequently ‘cured’ of the plasmid pEST by repeated culture in the absence of antibiotics.
When cultured without antibiotic selection, replication of extrachromosomal plasmids is no
longer necessary for survival (in most cases), and can be purged from the bacterium.
These antibiotic sensitive bacterial clones are thus said to be ‘cured’ of the plasmid. This
concept was utilized to isolate the transformation competent strain termed ‘pEST-cured
Bartonella' (‘PCB’, or ‘JB584’) which was used as the host strain in all subsequent genetic
manipulation experiments (Chapters Two, Three, and Five). By curing a pre-transformed
strain of B. bacilliformis, we found that an uncharacterized natural mutation occurred in the
host strain used by Grasseschi and Minnick (61) that allowed foreign DNA to survive and
replicate. Thus, ‘PCB’, designated B. bacilliformis strain ‘JB584’ was utilized in the
genetic manipulation experiments described in Chapters Three and Five. An illustration of
plasmid transformation is provided in Figure 2-A.

2.

Random Mutagenesis.

A second general technique for genetic manipulation is random mutagenesis. There
are various methods for accomplishing this procedure including UV irradiation, chemical
mutagenesis and transposon-mediated mutagenesis. UV irradiation and chemical
mutagenesis have the inherent disadvantage of possibly altering the genetic background of
mutants generated by this approach. These anomalous secondary mutations are of concern
when assessing the pathogenesis of an organism, for the virulence potential of a specific
gene and gene product are in question relative to a wild-type background.
Transposons are often used as a nonspecific technique for mutagenesis provided
there is a method for phenotypically or biochemically characterizing the mutants (50,59).
Transposon-mediated mutagenesis is the random insertion of a specific genetic element into
a genome. The advantage of transposon-mediated mutagenesis over chemical and UV-light
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induced mutations is that often a single gene can be mutagemzed and characterized in a
wild-type background. Disadvantages of transposon mutagenesis include random
insertion, multiple insertion, and phenotype-directed isolation. This method was attempted
for B. bacilliformis by electroporation mediated introduction of the plasmid pMGC20.
This plasmid contains T n i545- A3 and was not able to produce recombinants by this
method (personal communication, M.F. Minnick, 1995). However, Dehio and Meyer
recently reported successful conjugation between E. coli and B. henselae as a means of
plasmid transformation as well as delivering Tn5 transposons on suicide plasmids for
random gene inactivation (41). To date, conjugation has not been attempted by our
laboratory.

3.

Site-Specific Mutagenesis: Insertional Recombination.

A plasmid harboring an origin of replication that is not recognized by the recipient
organism is termed a suicide plasmid, or suicide vector, for it will never replicate unless
recombinauon with the genome occurs. If a target fragment of DNA is cloned into this
suicide plasmid, it is termed an O-type gene targeting construct. Thus, expression of the
resistance marker is a result of a single cross over, or single homologous recombination
event with the genome. This single cross over effectively disrupts the target gene provided
the target fragment in the suicide vector does not contain either end of the gene.
Recombinants generated with these methods are referred to as ‘knockouts’ or ‘null
mutants’ as expression of the target gene is interrupted. It is of course possible that
illegitimate recombination can take place between the suicide vector and a portion of the
genome other than the target This strategy of genetic manipulation has been employed to
inactivate a wide range of both prokaryotic and eukaryotic genes (68, 151, 159), and was
used in Chapter Three to mutagenize the B. bacilliformis flagellin gene. An illustration of
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insertional recombination is provided in Figure 2-B.

4.

Site-Specific Mutagenesis: Replacement Recombination.

Alternatively, linear or Q-type gene targeting constructs can be produced using one
of two methods. In the first method, a two-step PCR amplification procedure utilizing
overlapping primer sets generates a linear, Q-type construct designed to specifically replace
codons resulting in amino acid alterations. The utility of this technique is for generating
and studying the effect of single amino acid substitutions. We used this technique to
attempt demonstration of homologous recombination with the gyrB gene. However, we
never had success even with the transformation efficient strain JB584 mentioned above.
This method is illustrated in Figure 2-C.
The second general method of producing a linear, Q-type gene targeting construct
begins with the construction of a template plasmid in which an antibiotic resistance cassette
is flanked by contiguous target sequences. Subsequent restriction digestion or PCR of the
(target-(antibiotic resistance cassette)-target} generates a linear Q-type construct designed
to inactivate the target gene while simultaneously inserting a resistance cassette for
selection. Antibiotic resistance can only result from a double cross over event between the
contiguous target sequences and the genome. This method was attempted unsuccessfully
to demonstrate homologous recombination with the flagellin gene and is illustrated again by
Figure 2-C.

5.

Natural Mutations.

Although naturally occurring mutations are not a means of genetic manipulation,
these mutations can often provide information for the design of targeting constructs. By
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culturing B. bacilliformis in the presence of 0.1 pg/ml coumermycin A i, an antibiotic that
targets the GyrB protein, we isolated naturally resistant mutants that occurred at a
frequency of ~6 x 10-9. Sequence analysis of gyrB from 12 coumermycin A ^resistant
(couR) mutants of B. bacilliformis identified single nucleotide transitions at three separate
loci in the ORF. We hypothesized that introduction of PCR products incorporating the
point mutations corresponding to coumermycin Aj resistance would give rise to couR
recombinants. This information was used to design several linear Q-type gene targeting
constructs using methods described by Samuels etal. (163). Unfortunately, we were
unable to demonstrate homologous recombination by this technique in either wild-type or
‘PCB’ genetic backgrounds. However, in this study we isolated and characterized the first
natural mutants of any Bartonella species. These data are reported in chapter four of this
dissertation.

B.

Homologous Recombination
Homologous recombination is process that results in modified genetic linkage

relationships between genes or parts of genes. It is essential for chromosome segregation
(in eukaryotic cells), maintenance of genomic integrity, and the generation of diversity
(102). Mutational analysis in E. coli has identified at least 25 genes involved in the
process, several of which have redundant functions (102). The genetic and biochemical
models of homologous recombination are intricate and extensive. A cohesive explanation
of the biochemistry would require at least another chapter in this dissertation. I will instead
refer the reader to an excellent and thorough review of the biochemistry of homologous
recombination by Kowalczykowski etal. (102). Explanations concerning homologous
recombination are mentioned within this work where required for clarity.
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III.

RESEARCH SIGNIFICANCE AND GOALS
A system for genetic manipulation greatly facilitates investigation of the poorly

understood virulence characteristics of the Bartonella. The overall goal of this project was
to develop a system of genetic manipulation for Bartonella bacilliformis and to use this
system to satisfy molecular Koch’s postulates for the flagellum, a putative virulence factor.
First, we hypothesized that a system for genetic manipulation could be developed and
approached this hypothesis by experimenting with two separate loci of Bartonella
bacilliformis-, the gyrB gene and the flagellin gene.

Specific Aim 1: Optimize conditions for homologous recombination. After
several initial attempts at mutagenizing the flagellin gene via an O-type construct it became
apparent that there were genetic obstacles hindering in vivo homologous recombination.
This initiated an investigation into methods of alleviating restriction as well as biochemical
and metabolic manipulations which have been shown to increase the likelihood of
homologous recombination. Insertional inactivation and allelic replacement strategies (in
Specific Aims 2 and 3, respectively) were used to optimize the conditions for this event.
Results: After numerous biochemical and metabolic manipulations, two were able
to promote homologous recombination. First, a strain of Bartonella bacilliformis was
isolated by curing a plasmid pre-transformed strain. This strain, termed JB584,
demonstrated a 2000-fold increase in plasmid transformation efficiencies and was
successfully used as the host strain for genetic site-directed manipulation studies. Second,
the addition of low levels of methionine may have inhibited epigenetic recognition of
introduced foreign DNA or resulted in the induction of the SOS response, both of which
should hypothetically increase homologous recombination efficiencies. The genetic
constitution of JB584 as well as the enhancing properties of methionine still remain to be
determined. These methods of optimizing the conditions are covered in Chapter Two of this
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work.

Specific Aim 2: Demonstrate allelic inactivation of the B . b a cillifo rm is
flagellin gene.

The flagellin gene has been cloned and sequenced, and is extant in our

laboratory. Initially, subclones of the gene were made to produce a source of target DNA
for the generation of gene targeting constructs. From this, both Q-type (linear) and O-type
(circular) gene targeting constructs were generated. Each construct was separately
introduced by electroporation. Recombinants were selected by antibiotic resistance and
molecular characterization included PCR analysis, SDS-PAGE, Western blotting, and
TEM. Finally, complementation (introduction of the wild-type gene) of the flagellin mutant
was used to attempt restoration of the wild-type phenotype, and thus construct strains for
testing molecular Koch’s postulates (Specific Aim 4).
Results: After numerous attempts we developed a system for site-specific genetic
manipulation and were able to construct a mutant that no longer expresses flagellin.
Restoration of the mutation by transcomplementation restored both expression and
secretion of the flagellin subunits, the motility phenotype, and the virulence to wild-type
levels. This is the first report of site-directed mutagenesis and transcomplementation for
the Bartonella, as well as the first demonstration of molecular Koch’s Postulates for the
genus. These data, as well as the phenotypic and virulence properties of the strains are
reported in Chapter Three of this work.

Specific Aim 3: Demonstrate allelic replacement of the B. b a cillifo rm is
g y rB gene. Single point mutations in the gyrB gene can confer resistance to coumarin
antibiotics, thus providing a selectable phenotype and locus for replacement
experimentation. Initially, the wild-type B. bacilliformis gyrB gene was cloned and
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sequenced. We then isolated natural gyrB resistance mutants by growth in the presence of
coumermycin

Sequence analysis of these mutants provided data that were

subsequently used to produce Q-type (linear) gene targeting constructs which were
introduced by electroporation. Finally, selection of gyrB recombinants in the presence of
coumermycin A i was attempted.
Results: After numerous attempts using two separate gyrB loci, we were unable
to demonstrate recombination-generated mutants. This strategy of replacement
recombination differs from that in Specific Aim 2 in that this strategy requires two separate
homologous recombination events (as opposed to one), and utilizes a linear fragment of
DNA (in contrast to circular, supercoiled DNA molecules). This unsuccessful venture
coincides with numerous attempts using a linear strategy to disrupt the flagellin gene,
which were also abortive. Low levels of homologous recombination and/or the presence of
an exonuclease are just two of the possible mechanisms that inhibited allelic replacement
linear constructs.
Although we were not able to demonstrate allelic replacement of the gyrB gene, this
research lead to several interesting results. The B. bacilliformis gene encoding the B
subunit of DNA gyrase, gyrB, was cloned, sequenced, and characterized. The cloned B .
bacilliformis gyrB was expressed in an E. coli -S30 cell-free extract, and was able to
functionally complement an E. coli couR-ts gyrB mutant. We isolated and characterized
background mutants of B. bacilliformis resistant to coumermycin A i. Sequence analysis
of gyrB from 12 couR mutants of B. bacilliformis identified single nucleotide transitions at
three separate loci in the ORF corresponding to predicted amino acid substitutions. This
study describes the first isolation and characterization of background mutants conferring
natural resistance to an antibiotic for any Bartonella species and is described in detail in
Chapter Four.
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Specific Aim 4: Determination of phenotype and virulence of generated
flagellin mutants. Preliminary data suggest that the bacterium requires flagella to
invade erythrocytes. Scherer et al. determined that rabbit anti-flagellin antibodies decreased
human erythrocyte invasiveness by nearly 98%, and adhesion by approximately 50%
(164). In addition to motility, the flagella of B. bacilliformis has been speculated to be
involved in attachment to erythrocytes (164,179), and the surface exposure will make it a
good vaccine candidate. Thus, we developed a system of genetic manipulation and used the
system to construct flagellin mutants and complemented mutants (Specific Aim 1). We
then assessed the phenotypic and virulence properties of the mutant and transcomplement
by using protocols adapted from previous experimentation (14, 164, 179).
Results: The non-motile mutant was unable to swim through a Bartonella motility
medium, which we developed, and demonstrated a decreased ability to adhere to human
erythrocytes (Chapter Three). The complemented fla.- mutant exhibited a swimming
phenotype that was indistinguishable from wild-type and recovered the ability to adhere to
erythrocytes (Chapter Three). These data demonstrate that the flagellum of B. bacilliformis
is indeed a virulence factor used by the bacterium to adhere to human erythrocytes. This is
the first demonstration of molecular Koch’s postulates (49) for any of the Bartonella, and is
described in Chapter Three of this dissertation.
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CHAPTER TWO
Optimization of the Conditions for
Hom ologous Recombination

I.

INTRODUCTION
This section of the dissertation was not anticipated but became necessary after

several initial attempts at mutagenizing the flagellin gene were unsuccessful. The overall
goal of this research required the demonstration of homologous recombination, and it was
realized early on that a combination of techniques would be necessary to achieve that goal.
This section discusses the standard protocols and variations of these protocols that were
employed to promote recombination or deter nuclease digestion of foreign DNA.

II. MATERIALS AND METHODS

A. Bacterial Strains and Culture Conditions.
B.

bacilliformis was grown on heart infusion agar (Difco) supplemented with 5%

defibrinated sheep erythrocytes and 2.5% filter sterile sheep serum (Quad Five, Ryegate
MT) at 30°C in a water-saturated atmosphere. Where needed, antibiotic supplements for B.
bacilliformis were 20 pg/ml kanamycin sulfate, 9 pg/ml chloramphenicol, and 0.1 fig/ml
coumermycin A i (Sigma Chemical Co., St. Louis, Mo.) and coinciding with the
experimental conditions were used individually or combined. Growth is usually observed
after 3 days and cells were generally harvested after 5 days. All experimentation was
performed in a laminar flow hood (Nuaire, Plymouth MN) to isolate this class II pathogen
as well as to prevent bacterial and fungal contamination of cultures that will thrive on the
rich medium.

42
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Figure 1. An illustration of potential obstacles impeding homologous
recom bination.
A . The restriction modification system. The restriction enzyme recognizes foreign
methylation patterns on DNA and subsequently fragments this DNA. In addition, Sadenoslymethionine (SAM) is the methyl donor for the cognate methylase and can be
reduced by low level methionine exposure. B . Exonucleases could potentially be
fragmenting the introduced DNA. C . The uncharacterized phage residing in B .
bacilliformis might also affect the event D . RecA, the mediator of homologous
recombination, must be activated and available for the event to occur. Also depicted are the
protocol modifications that initiate the SOS response and have been shown to indirectly
result in the activation of RecA.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permi
Chromsom

I

Gene X

M

I

I

M M

Restnction Enzymets
DNA methylase~>

cO

©

©

Z

single-stranded DNA

Uv-light I
I

Denatured or cross-linked
DNA

methionine~~|

C jn a c tiv e -re cO

L inear/ds p h ag e

O ctived-recA j>

C]j ^ * o n u c lc a sc Z-^

Gene targeting constructs

45

Escherichia coli strains used for propagation of cloned genes were grown overnight
at 37°C in Luria-Bertani medium with standard antibiotic supplements where required (39).

B. Preparation and Manipulation of DNA
Chromosomal DNA from B. bacilliformis was prepared using CTAB
(hexadecyltrimethyl ammonium bromide) by the methods of Ausubel et al. (9). Plasmid
DNA extraction and isolation from E. coli for cloning was performed by the alkaline lysis
procedure of Bimboim and Doly (18). Ultrapure plasmid DNA prepared for
electroporation experimentation was prepared by Qiagen (Chatsworth, Calif.) Midi-prep kit
or a 5 PRIME-3 PRIME (Boulder,CO) Perfect Prep kit as per the manufacturer’s
instructions. Restriction digestion of the DNA utilized numerous enzymes from several
suppliers; Promega (Madison, WI), New England Biolabs (Beverly, MA), American Allied
Biochemicals (Aurora, CO), and Gibco BRL (Gaithersburg, MD). The cloning of
individual DNA fragments was accomplished by purifying DNA from
ethidium-bromide-stained agarose gels by either a GeneClean kit (Bio 101, La Jolla, Calif.)
or by a QIAquick kit (Qiagen). Ligation and transformation of the fragments into E. coli
DH5 a was achieved by utilizing standard procedures (162). In addition to the standard
procedures, T-vectors (Novagen, Madison, WI) were used for cloning PCR products,
linkers (Promega), T4 polymerase (Promega), and SI Nuclease (Promega) were used
depending on the conditions of the cloning.

C. Electrocompetent Cell Preparation

1. Standard protocol
There are many factors involved in the preparation of electrocompetent cells that
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influence the overall viability and efficiency of transformation (109). B. bacilliformis
KC584 was grown as stated above and harvested with an ethanol-sterilized razor blade.
Approximately 7 plates of 5-day-old cultured cells were harvested into 1 ml of 4°C heart
infusion broth. The cells were subsequently washed 4 times with 1 ml ice cold 10% (v/v)
glycerol-water with intermittent centrifugations at 2090 x g for 20 min at 4°C. The final
bacterial concentration was measured with a Petroff-Hauser counter and adjusted to lxlCh 0
cells/ml with 10% glycerol.

2.

Variations of standard cell preparation

a. Enhanced transformation rates have been correlated with high temperatures of
growth (personal communication, K. Orzech, 1996). Abbott etal. have attributed this
stimulation to a thermally-induced SOS response, thus activating the homologous
recombination mediator, RecA (1). Therefore, as an anti-restriction enhancement, cells
were grown at 37°C for 5 days prior to harvest for electrocompetency.
b . UV light-induced SOS induction has been correlated with temporary alleviation
of host-controlled restriction in Cyanobacterium, Bacillus, and E. coli (47, 74, 75, 178,
187). As an anti-restriction enhancement, the cells were irradiated with UV light at
approximately 32 J/m2 with a standard 15-W germicidal bulb prior to harvest
Unfortunately, the obvious disadvantage of UV-light induced SOS is the potential
for nonspecific mutation of genes involved in virulence and thus render suspect the
definitive genotype of mutants generated by this approach.
c . Growth in the presence of methionine has been shown to decrease the levels of
S-adenosylmethionine (SAM) in vivo (78,165). SAM is the methyl donor for DNA
methylases and is also required for the function of Type I restriction enzymes (17). Thus,
as an anti-restriction enhancement, the normal B. bacilliformis growth medium described
above was supplemented with 5 mM methionine (Sigma).
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D. Electroporation

1. Standard protocol
Electroporation of 44 pL bacterial suspension with 1-2 pi DNA were performed
using a Bio-Rad Gene Pulser with 0.2-cm cuvettes (BioRad Laboratories, Hercules CA.)
that have been chilled on ice for at least 1 h. The Gene Pulser configuration is as follows;
exponential decay waveform set at a field strength of 12.5 kV/cm, a pulse time of 5 msec,
and capacitance held constant at 25 pF. These parameters were optimized by Grasseschi el
al. and are similar to those for other closely-related bacteria (61, 149).

2.

Variations of the standard electroporation protocol

a . It has been demonstrated that RecA in E. coli is activated upon induction of SOS
and that RecA is required for, and can even stimulate homologous, recombination in vivo
(1, 107, 145). Furthermore, single-stranded DNA has been shown to induce the SOS
response in vivo (56). Therefore, as an anti-restriction measure, electroporation mixtures
described above were supplemented with nonspecific single-stranded oligonucleotides
synthesized by Joan Strange at the Murdock Molecular Biology Facility at the University of
Montana.
b. The standard 10% (v/v) glycerol-water employed in the electroporation
suspension was modified several ways according to transformation procedures developed
for other microorganisms (51). Addition of 1 mM MgCl2 to the suspension and an increase
in glycerol concentrations to 20% were utilized in an attempt to increase transformation
efficiencies.
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E. Post-Electroporation Treatment

1. Standard protocol
Immediately following electroporation, the cells were removed from the cuvette by
resuspending in a sterile recovery broth modified from Benson el al. (heart infusion broth
containing 0.5%(w/v) bovine serum albumin and 5% (v/v) sheep erythrocyte lysate)(4).
The erythrocyte lysate was made by mixing one volume of defibrinated sheep erythrocytes
with one volume of 4°C sterile d t^ O followed by centrifugation (4 min at 16 000 x g) to
remove cellular debris. The cells and recovery broth were then transferred to a 15 ml sterile
glass test tube and incubated for 14 h at 30°C in a water-saturated atmosphere, which
corresponds to approximately two B. bacilliformis generation times (14). This incubation
period was provided to allow time for recombination of the specific construct and for
antibiotic resistance marker expression.
After this short incubation, cells were plated by transferring the 1 ml of suspension
to a microcentrifuge tube, centrifugating at 2090 x g for 20 minutes to pellet the cells, and
removing 900 t*l of the supernatant. The cell pellet was resuspended in the remaining 100
p.1 and plated on heart infusion agar supplemented with 5% defibrinated sheep erythrocytes
plus antibiotic, and subsequently grown at 30°C in a water-saturated atmosphere.
Antibiotic supplements of 20 pg/ml kanamycin sulfate, 9 pg/ml chloramphenicol, and 0.1
pg/ml coumermycin A i were used individually or combined and coincided with the
experimental conditions. According to Grasseschi et al., colonies appear after 6 d of
incubation in clones transformed with the replicative cosmid pEST (61).
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2. Variations on the standard post-electroporation treatment
a . The 14 h of nonselective growth following electroporation has been shown to
provide ample time for expression of resistance genes from a multicopy extrachromosomal
locus. We hypothesized that the single copy nature of an integrated or chromosomal locus
marker may require a longer period of nonselective growth to accumulate the resistance
proteins, the nonselective growth time was therefore extended to 48 h.
b . As stated above in section C, low-level methionine exposure causes a reduction
in the levels of S-adenosylmethionine (SAM) in vivo (78, 165). SAM is required for Type
I restriction enzymes and is also the methyl donor for DNA methylases (17). A reduction
in methylation should disrupt the constitutive restriction-modification system by inhibiting
the methylation of chromosomal DNA and subsequently cause misinterpretation and
restriction of self-DNA. This hypothetically results in an SOS response that, as stated
above, enhances homologous recombination in vivo while concurrently activating RecA,
the mediator of homologous recombination (145). For these reasons, the recovery broth
was supplemented with 5mM methionine to stimulate a nonspecific, non-mutational (ie.
UV-light) SOS induction.

F.

Selection of the most efficient Gene Targeting Construct:
After several initial unsuccessful attempts at mutagenizing the flagellin gene using

suicide plasmids, we were prompted to experiment with all known methods of in vivo
homologous recombination. Generalized transposon mutagenesis and interplasmid
recombination as well as the O-type and Q-type targeting constructs were utilized in an
attempt to demonstrate in vivo homologous recombination. Brief descriptions of these
strategies are as follows:
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1. Transposons are often used as a nonspecific technique for mutagenesis
provided there is a method for phenotypically or biochemically characterizing the integrants
(50,59). We hypothesized that flagellin mutants could be isolated by loss of motility and
therefore introduced pMGC20 that contains Tnl545-A3 (168). As with UV-light-induced
mutagenesis, this generalized system may cause anomalous mutations affecting virulencerelated genes and render suspect the definitive genetic composition of mutants generated by
this approach.
2. In an attempt to demonstrate interplasmid homologous recombination, the
plasmid designated pPX was introduced into the pEST-containing strain generated by
Grasseschi et al.(61). In brief, this plasmid has a pMB 1 origin of replication that is not
recognized by B. bacilliformis, and thus the chloramphenicol marker will only be
expressed when interplasmid recombination occurs between pEST and the 6000bp
EcoRI/Xmnl pEST fragment cloned into pPX.
3 . Three different O-type constructs (suicide plasmids), including pJMB 1Aamp,
pJPFLAG688 and pUB508 were generated with different kanamycin cassettes harboring
individual regions of the flagellin gene. Each was subject to the alterations described in
section G after standard procedures yielded no recombinants. An illustration of the three
suicide plasmids is provided in Figure 2.
4 . Several linear, Q-type constructs were made. Template plasmids pFILA2
(kanamycin resistance) and pFLAGCAT (chloramphenicol resistance),were used to
generate the Q-type constructs via PCR amplification and used for flagellin gene
recombination. This Q-type flagellin inactivation requires the insertion of a large antibiotic
resistance cassette via a double cross over. As with the O-type, these approaches were
initially unsuccessful and were subject to the alterations described in section G, above.
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Figure 2.

Attributes of three of the O-type gene targeting constructs used

in this study. Also termed suicide plasmids, these constructs were designed to
inactivate the flagellin gene of B. bacilliformis. The hatched lines indicate flagellin
fragments and the kanamycin cassettes are indicated as neomycin phosphotransferase (npt)
type I or II. The noted origins of replication, pMBl and R6K, are not recognized by
Bartonella (Grasseschi eta/., 1994; Reschke etal., 1990).
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Figure 3. One of the strategies utilized to produce an Q-Type gene
targeting construct for replacement recombination with the flagellin gene.
The template plasmid, pFILA2 and the amplimer set Fla5/Flal200 were used to PCR
amplify the linear construct illustrated. Hatched lines indicate flagellin sequence, and the
kanamycin resistance cassette nptl is also shown. A double cross over event at a
chromosomal locus will hypothetically insert the resistance cassette and interrupt the
flagellin gene.
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Figure 4.

Generation o f constructs Q-Type gene targeting constructs for

replacement recombination of the g yrB gene. The first step utilizes amplimers that
overlap each other (672F / 642R) and harbor individual base substitutions. Upon
polymerization, these amplimers become integrated into the fragments produced in A. A
second PCR involves a 3 cycle thermocycler assembly of these fragments (in the absence
of amplimers) and a 30 cycle amplification of the now assembled fragment with the
amplimers 354F and 1128R. The result of the reactions is shown in B, a linear construct
that has base changes (6) designed to produce a single amino acid substitution shown to
result in coumermycin A i resistance. (This strategy was adapted from Samuels etal. ,
1994.)
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Figure 3 (p. 53-4) depicts one of the strategies used to generate linear constructs for
replacement recombination with the flagellin locus.
The gyrB locus provides a means to demonstrate in vivo homologous
recombination. By replacing a single codon (rather than inserting an antibiotic resistance
cassette) in the gyrB gene via the Q-type approach, an amino acid substitution results in
coumermycin A i resistance. This Q-type approach was used in replacement
experimentation with the gyrB gene and is summarized in Figure 4 (p. 55-6).

G. Treatments to constructs
1. Standard protocol
After initial attempts to demonstrate in vivo homologous recombination were futile,
modifications to standard protocols were utilized to promote the event The following set
of modifications focused on the treatment of the gene targeting construct prior to
introduction by electroporation. Each treatment was designed to either promote
homologous recombination via SOS induction of RecA or protect the construct from the
endogenous restriction/modification systems.
2.

Variations of standard construct treatment

a . Abbott et al. have demonstrated that insertional (O-type) homologous
recombination is stimulated by UV-treatment of the suicide plasmid prior to introduction
(1). Thus, as a protocol modification certain constructs were exposed to UV light at
3 0 0 m J /m 2

prior to introduction by electroporation.

b . In a similar notion, certain constructs were denatured by heating to 98‘C in a
microcentrifuge tube and immediately plunged into an ice bath. These denatured constructs
were then introduced into the cells by electroporation. The hypothesis was that the single
stranded DNA would induce the SOS system and thus activate RecA.
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c . Inherent in the Q-type approach is the unavoidable introduction of
non-methylated DNA viaTaq polymerase. On the suggestion of P.F. Sparling (personal
communication, 1996) several attempts were made to introduce a replicative vector with a
fragment of the flagellin gene into B. bacilliformis, and allow the organism to modify the
DNA in vivo. Subsequent preparation of the B. bacilliformis-modified construct was then
restricted, purified (QiaSpin), and reintroduced into the organism by electroporation.

H.

Isolation of a transformation competent strain
1. Standard protocol
The last application of a manipulation to the standard site-specific recombination

protocols involved the strain of B. bacilliformis. Subsequent to the failed attempts
mentioned, we examined the transformation rates of several strains of B. bacilliformis.
2.

Variations of standard strains

a . In addition to the ATCC type strains 583 and 584, we obtained an apparent
methylase minus strain of B. bacilliformis KC584 from L. Hendrix (Texas A&M
University). The negative methylase character was demonstrated by the ability of normally
non-recognizing restriction enzymes to fragment chromosomal preparations of this strain
termed KC584-long passage. If the methylases are nonfunctional then it is very possible
that the restriction system is also somehow altered, for a normally functioning restriction
system would recognize the non-methylated DNA as foreign and the strain would never
survive. Introduction of gene targeting constructs was performed on this strain.
b . Finally, the pEST-containing strain of B. bacilliformis generated by Grasseschi
etal. was cured of the cosmid by growing on nonselective medium for 3 passages.
Individual colonies were picked with a sterile needle and subcultured independently.
Kanamycin sensitivity. Southern analyses (pEST and nptl probes), and PCR analyses (nptl
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primer set) demonstrated that the pEST cosmid is no longer in this strain. It was thus
nicknamed PCB for pEST cured Bartonella bacilliformis, and subsequently redesignated
JB584.

III.

RESULTS
By using the pUB508 suicide vector (Fig. 2), we were able to demonstrate site-

specific homologous recombination and concurrent construction of the first characterized
mutants of any Bartonella. The data concerning construction of the flagellin mutants,
JB585 and JB586 are presented in Chapter Three of this work. Here, we were concerned
with protocol alterations that would increase the likelihood of homologous recombination.
Two independent alterations of the standard protocols may have promoted the event. First,
as explained in section H, above, the PCB (JB584) strain of B. bacilliformis
demonstrated a 2000-fold increase in plasmid transformation efficiencies with the
replicative plasmid pBBRlMCS-2. Using this strain as the host strain for site-directed
mutagenesis experimentation proved successful (Chapter Three). Second, the addition of
methionine to the recovery broth may have also encouraged the homologous recombination
event However, the efficacy and underlying mechanism for this protocol alteration still
remains to be determined.

III.

DISCUSSION
The event of site-specific in vivo homologous recombination requires that the

introduced DNA evade host exonucleases and endonucleases, find a genomic homolog,
and recombine. The host is able to differentiate self from non-self DNA by an epigenetic
pattern of methylation on the DNA. DNA that does not have the host-specific pattern is
recognized by restriction endonucleases and subsequently digested, or ‘restricted’ from the
cell. After numerous attempts using wild-type B. bacilliformis KC584 and KC583, not a
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single recombinant was isolated.
To avoid this restriction, the obvious method was to methylate the introduced DNA
such that it matched the host’s pattern. We attempted to determine the methylation pattern
by collaborating with a specialist in this field but this approach was too costly to pursue.
We hypothesized that the restriction system was inhibiting survival of introduced foreign
DNA, and therefore designed protocols that would hypothetically ‘confuse’ the
self/non-self recognition. Low level methionine exposure should hypothetically reduce
SAM and thus inhibit normal genomic DNA methylation. The cell would then begin to
restrict its own genomic DNA. This induced misinterpretation between self and non-self
may have allowed the foreign DNA to escape restriction and eventually recombine. The
mechanism of methionine promotion of in vivo homologous recombination remains to be
tested.
In contrast, the major factor that enhanced the in vivo homologous recombination
event in B. bacilliformis was creation of the transformation efficient host strain PCB
(JB584). The high efficiencies of plasmid transformation with pBBRlMCS-2 were
independent of methionine. Again, a 2000-fold increase in plasmid transformation
efficiencies prompted us to attempt mutagenesis experiments with JB584. It is obvious that
the uncharacterized natural mutation(s) in this strain permits replication host-specific
methylation, and subsequent extrachromosomal maintenance. Genomic DNA from JB584
retains the wild-type methylation pattern based on the inability of certain methyl-specific
restriction enzymes to digest This suggests that JB584 has a restriction system mutation
that enables foreign DNA to survive. In contrast, it is interesting to note that the
high-passage KC584 strain mentioned above (section H), which apparently lacks DNA
methylation (based on the ability of certain methyl-specific restriction enzymes to digest)
did not demonstrate an increase in plasmid transformation efficiencies. One would expect a
methylase minus strain to accordingly be restriction minus to avoid restricting its own
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DNA. The natural mutation(s) in strain PCB (JB584) remain to be determined.
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CHAPTER THREE
Site-Directed Mutagenesis and Transcomplementation of the
Bartonella bacilliform is Flagellin Gene.
James M. Battisti & Michael F. Minnick.
Anticipated submission to Infection and Immunity, July 1998

A BSTR A CT
The lack of a system for site-specific genetic manipulation has severely hindered
studies on the molecular biology of Bartonella species. We report the first demonstration
of site-directed mutagenesis and transcomplementation for any Bartonella species, using the
B. bacilliformis flagellin gene (Jla) as a target. A highly competent strain of B .
bacilliformis was isolated by curing a KC584 strain that had previously been transformed
with the cosmid pEST. This strain, designated JB584, demonstrated a 2000-fold increase
in transformation efficiencies, using the broad-host-range plasmid pBBRlMCS-2, relative
to wild-type strains. A suicide plasmid, pUB 1, was constructed with a pMB 1 replicon
and the neomycin phosphotransferase I gene (nptl). Recombinant DNA containing the
cloned fla gene was isolated from a \ ZAP genomic library by screening with polyclonal
anti-flagellin antiserum. An internal 508-bp fragment of the fla gene was then cloned into
pUB 1 to generate pUB508. The flagellin gene of JB584 was then insertionally
mutagenized by electroporation-mediated introduction of pUB508 and subsequent
homologous recombination. Characterization of two of eight kanamycin-resistant clones
(JB585 and JB586) by PCR analysis and Southern blots indicated that allelic exchange
with the suicide plasmid had occurred. Analysis by SDS-PAGE, immunoblots, and
transmission electron micrographs showed that expression, secretion, and assembly of the
42-kDa flagellin polypeptide encoded by jla was also abolished. Finally, JB585 was
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found to be nonmotile when compared to KC584 and JB584 using motility medium or
phase contrast microscopy. In trans complementation was accomplished by transformation
with a pBBRlMCS derivative, pBBRFLAG, containing the entire wild-type Jla gene.
Transcomplemented strains exhibited flagellin expression, flagellum assembly, and motility
that was indistinguishable from wild type strains. These data conclusively show that
pMBl and pBBRl replicons make suitable B. bacilliformis suicide and shuttle plasmids,
respectively. Finally, in in vitro human erythrocyte adhesion assay, the fla- strain
demonstrated a significant loss in adhesion relative to control strains, which strongly
suggest that the flagellum is a virulence determinant involved in the pathogenesis of B.
bacilliformis.

IN TROD UCTIO N
The bartonellae are a unique group of intracellular bacteria that employ
arthropod-mediated transmission and hemotrophy as common parasitic strategies. Five
Bartonella species are presently considered agents of emerging infectious disease in
humans (B. bacilliformis, B. clarridgeiae, B. elizabethae, B. henselae, and B. quintana).
Diseases caused by Bartonella include endocarditis, cat-scratch disease, bacillary
angiomatosis, bacillary peliosis and trench fever; several of which are manifested in AIDS
patients (for recent reviews, see references 19 and 27). B. bacilliformis is the etiologic
agent of Oroya fever and verruga peruana, and is indigenous to the Andes mountain range
of South America. The primary phase of the disease, termed Oroya fever or Carrion’s
disease (13), is characterized by an acute fulminant anemia and has a 40% - 80% mortality
rate in the absence of antibiotic treatment (17,23). Humans present with this hematic
phase of the disease within two to three weeks following inoculation of bartonellae into the
bloodstream by the bite of a nocturnal sandfly (17). The chronic secondary phase of the
disease, termed verruga peruana, develops weeks to months after inoculation and is
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characterized by blood-filled cutaneous eruptions on the extremities (17). During this
phase, B. bacilliformis invades vascular endothelial cells (11, 12,25), a common event in
other bartonelloses.
Although little is known of the molecular mechanisms involved in the pathogenesis
of B. bacilliformis, reports have implicated the lophotrichous flagella (23) as a putative
virulence factor in both adherence to, and invasion of, human erythrocytes. First, in the
presence of anti-flagellin antiserum, erythrocyte association is attenuated by 50% and
invasion is reduced nearly 100% relative to controls (40). Second, observation of B .
bacilliformis interaction with erythrocytes by Namarski optics demonstrated that the
bacteria use a boring or twisting motion that is accompanied by a remarkable deformation
of the erythrocyte surface (2). Third, motile cultures of B. bacilliformis have been shown
to have a higher rate of attachment and entry into erythrocytes (2,26), and that the invasion
requires energy exertion by the bartonella but not by the erythrocyte (44). In addition to
flagellar-mediated mechanisms, two virulence factors termed deformin (26,45) and
IalA/IalB (29) have been reported to contribute to pathogenicity. These findings strongly
suggest that a forced endocytosis entry into erythrocytes requires flagellar-mediated
motility.
In order to provide irrefutable evidence regarding the virulence role of the flagella,
or any other suspected virulence factors from a Bartonella species, a strategy for
site-directed genetic manipulation is essential. In this report we describe a system of allelic
exchange and transcomplementation for the B. bacilliformis flagellin gene and determine
the effect of the mutation on motility and adhesion to human erythrocytes. This is the first
report of site-specific mutagenesis and complementation for any Bartonella, and more
importantly, the first demonstration of molecular Koch’s postulates.
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MATERIALS AND METHODS

Bacterial strains and culture conditions. Escherichia coli strains used for
propagation of cloned genes were grown overnight at37°C in Luria-Bertani medium with
standard antibiotic supplements where required (6). Strains of B. bacilliformis and E. coli
used or generated in this study are summarized in Table 1. B. bacillifomus was routinely
grown on heart infusion agar (Difco, Detroit, MI) supplemented with 5% defibrinated
sheep erythrocytes and 2.5% filter-sterile sheep serum (Quad Five, Ryegate, MT) at 30°C
in a water-saturated atmosphere. Antibiotic supplements used in this study for B.
bacilliformis were 25 pg/ml kanamycin sulfate, and 1 pg/ml chloramphenicol (Sigma
Chemical Co., St. Louis, MO), which were used individually or combined depending upon
experimental conditions. Colonies were usually observed 3 days after inoculation and cells
were generally harvested after 5 days growth.
For testing the motility of B. bacilliformis strains, a Bartonella motility medium
was devised. The defibrinated sheep erythrocyte supplement of normal growth medium
was replaced with sheep erythrocyte lysate (2) at an equivalent 5% concentration to yield a
translucent medium appropriate for this analysis. Second, the agar in the medium was
reduced to 0.2% (w/v). Plates were poured and dried for 48 h at 22°C and for an
additional hour at 45°C prior to inoculation to reduce surface moisture of the agar.

Preparation and manipulation of DNA. Chromosomal DNA from B. bacilliformis
for use in DNA hybridization analysis or PCR analysis was prepared using CTAB
(hexadecyltrimethyl ammonium bromide) by the methods of Ausubel et al. (1). Plasmid
DNA extraction and isolation from £. coli for cloning was performed by the alkaline lysis
procedure of Bimboim and Doly (3). Ultrapure plasmid DNA prepared for electroporation
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pUC18 containing 1400-bp Hindlll/EcoRI fragment of pAULl with
Jla gene, Repa, Apf
Complementation shuttle vector. pBBRlMCS containing 2158-bp
tfrndlll fragment of pAULl with/fa gene, Repa. Repub. Cm'

pFLAQ3

pBBRFLACJ

pAULl

pUB508

plJBl

pUC18 containing Km' cassette(n/?//), Repa, Apr, Kmr
pUC19 containing ~1500-bp Psi\ fragment of pUCKI8,
Repa, Apf, Km'
Suicide plasmid. p(JCK19 with a 1118-bp flj/II fragment removed to
delete bla gene, Repa. Km'
Flagellin targeting suicide plasmid. pUBl containing 508-bp KpnllBglll
fragment of /fa, Repa. Km'
pBK-CMV containing 3800-bp B. bacilliformis 5au3AI fragment
with f!a gene, Repa, Kni'

Cloning vectors, Repa, Ap1
Genomic library cosmid, Repa, Kmr
B. bacilliformis shuttle vector, Repa, RepHb, Cm'
B. bacilliformis shuttle vector, Repa. BepBb, Km'

Host strain used for cloning and propagation of pUB508 and pBBRR.AG

Virulent wild-type strain
KC584 transformed with pEST |Km'|
110584 cured of pEST |Km*J
Jla gene of JB584 interrupted by insertion of pUB508 |Kmr, Jhr]
Isogenic to JB585 [K m ',/fa]
JB585 flagellin gene complemented in irons by transformation
with pBBRR.AG |Kmr, Cm', Jla*]

Relevant characteristics

pUCKI8
plJCK19

pBBRlMCS-2

’lasmids
pUC18,19
pBK-CMV
pBBRlMCS

DH5a

E. coli

Strains
B. bacilliformis
KC584
HQ584
JB584
JB585
JB586
JB686

Strain or plasmid

TAD1.H 1 Bacterial strains and plasmids used in this study

study
study
study
study

This study

This study

This study

This study

This study

(35)
This study

(21)

(46)
(42)
(22)

(14)

(4)
(16)
This
This
This
This

Source/Reference

experimentation was prepared using a Midi-Prep kit (Qiagen, Chatsworth, CA) or a Perfect
Prep kit (5 PRIME-3 PRIME, Boulder, CO) as per the manufacturer’s instructions. The
cloning of individual DNA fragments was accomplished by purifying DNA from ethidium
bromide-stained agarose gels by either a GeneClean kit (Bio 101, Inc., La Jolla, CA) or by
a QI Aquick kit (Qiagen). Ligation and transformation of the fragments into E. coli DH5a
was done by standard procedures (39). Plasmids used or constructed in this study are
summarized in Table 1.

DNA Hybridization analysis.

Total DNA fromB. bacilliformis KC584, HG584,

JB584 and pEST cosmid DNA were isolated, digested to completion with BamHI, and
then separated on an ethidium bromide-stained 1 % agarose (w/v) gel. The gel was then
blotted onto nitrocellulose membrane (0.45-p.m-pore-size; Schleicher & Schuell, Keene,
NH) by the method of Southern (41) and baked for 1 h at 80°C. The cosmid pEST (35)
was isolated with a Perfect Prep kit (5 PRIME-3 PRIME) and labeled by random primer
extension (10) with the Klenow fragment of E. coli polymerase I (Gibco-BRL) and
[a-32p]dCTP (New England Nuclear, Boston, MA). The blot was probed overnight at
50°C with the 32P-labeled pEST cosmid and washed as previously described (28). The
blot was subsequently exposed for 1 h to X-ray film (X-Omat XAR-5; Eastman Kodak
Co., Rochester, NY) to visualize hybridized DNA fragments.
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Electroporation. B. bacilliformis strains were grown as stated above. Approximately
seven plates of 5-day-cultured cells were grown as stated above and were harvested into 1
ml of 4°C heart infusion broth. The cells were subsequently washed four times with 1 ml
ice cold 10% glycerol-water (v/v) with intermittent centrifugations at 2090 x g for 20 min
at 4°C. The final bacterial concentration was measured with a Petroff-Hauser counter and
adjusted to lxlO10 cells/ml with 10% glycerol. Electrotransformation was performed using
a Bio-Rad Gene Pulser with 0.2-cm cuvettes (BioRad Laboratories, Hercules, CA) that
had been chilled on ice for at least 15 min. In general, a 44 pi bacterial suspension ( lx 10*°
cells/ml) was combined with 1 to 2 pi DNA (1 to 44 pg/pl) and electroporated with an
exponential decay waveform set at a field strength of 12.5 kV/cm, pulse time of 5 msec,
and capacitance of 25pF as previously described for Bartonella(16,35). Immediately
following electroporation, cells were removed from the cuvette by resuspending in 1 ml
ice-cold sterile recovery broth modified from Benson et al. (heart infusion broth containing
0.5% (w/v) bovine serum albumin 5% (v/v) sheep erythrocyte lysate and 5 mM
L-methionine) (2). The cell-recovery broth suspension was then transferred to a 15 ml
sterile glass test tube and incubated for 14 h at 30°C in a water-saturated atmosphere. This
incubation period corresponds to approximately two B. bacilliformis generation times (2)
and was provided to allow time for antibiotic resistance marker expression. Transformants
were isolated by plating on standard Bartonella growth medium supplemented with
kanamycin and/or chloramphenicol. Antibiotic resistant colonies usually appeared after 6 to
7 days of incubation at 30°C.
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PCR and oligonucleotides. PCR amplification was achieved by using a GeneAmp
2400 Thermocycler (Perkin Elmer, Norwalk, CT) following procedures developed by
Mullis etal. (32). Reaction mixtures contained lOmM Tris-HCl, pH 8 3 , 50 mM KC1, 200
pM each deoxynucleotide triphosphate, 4 mM MgCl2 , 2.5 U AmpliTaq DNA polymerase
(Roche Molecular Systems, Branchburg, NJ), 1 to 100 ng template DNA, and 0.1 fig of
each primer. The reaction proceeded for 30 cycles of 1 min at 94°C, 1 min at 50-60°C
(depending on calculated primer melting temperature), and 1 min at 72°C, with an initial 5
min denaturation at 94°C and a final 7 min extension at 72°C. Single-stranded
oligonucleotide primers specific for the flagellin gene, Fla 5’
(5’-AAGCTTTAGAGATTGTTTTGCAAA-3’), Ha 1300(5’AAAT ATT CT GGCT GCCCT GATTT GC-3 ’) and the kanamycin cassette, NptI 5’(5’AGCCACGTTGTGTCTCAAAATCTC-3’), NptI
3’(5’-CGTCCCGTCAAGTCAGCGTAATGC-3’) were synthesized by The University of
Montana Murdock Molecular Biology Facility. Target loci for each of the primers are
schematically illustrated in Figure 1.

SDS-PAGE and immunoblotting. Whole-cell extracts of mutant strains and wild type
controls were separated on sodium dodecyl sulfate-polyacrylamide gels (12.5%
acrylamide) using procedures adapted from Laemmli (24). Protein bands were visualized
by staining with Coomassie brilliant blue (39). For immunoblots, separated proteins were
electrophoretically transferred from gels to nitrocellulose membranes (0.45-p.m-pore-size;
Schleicher and Schuell) by the methods of Towbin etal. (43). Immunoblots were
developed using the procedures of Scherer el al. (40). Briefly, the blot was blocked with
0.3% Tween-20, 2% skim milk in phosphate buffered saline (PBS) pH 7.4 for 2 h at
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22°C. Incubation with rabbit-anti B. bacilliformis flagella antisera was followed by a
secondary horse radish peroxidase-conjugated goat anti-rabbit IgG (Sigma), and finally
developed with PBS containing 4-chloro-l-napthoI and H2 Q 2 .

T ransm ission electron m icroscopy. B. bacilliformis was grown as stated above and
harvested into 1 ml heart infusion broth at 4°C. The cells were washed 3 times with 4°C
10% glycerol (v/v) with intermittent centrifugations at 2090 x g for 20 min at 4°C and
resuspended in 10% glycerol. 15 pi aliquots of this suspension were placed on Formvar
(Pelco, Tustin, CA) coated 300 mesh copper-palladium grids (Electron Microscopy
Sciences, Fort Washington, Pa.) and incubated for 5 min at 22°C. The grids were then
stained with 2% uranyl acetate (pH 7.0) for 3 min, de-stained with 1 M ammonium acetate
(pH 7.0) for 3 min, and washed with deionized water for 1 min. The grids were then
air-dried and observed at 75 kV with a model 7100 transmission electron microscope
(Hitachi, Mountain View, CA) located at the University of Montana Electron Microscope
Facility.

E rythrocyte adhesion assay.

Seven plates of each strain (KC584, JB584, JB585,

and JB686) were grown for 5 days on heart infusion agar supplemented with sheep
erythrocytes, serum, and antibiotic (where required) as described above. Bartonella were
subsequently harvested into 1 ml Bartonella liquid growth medium, or BLGM (minimum
essential medium eagle, or MEM (Vitacell-ATCC, Rockville, MD), supplemented with
10% -SRBC lysate [as described above]), at 4°C. After gentle resuspension with a pipettor,
each suspension was clarified of bacterial and agarose clumps by a 5 min incubation at 4°C
after which the supernatant was transferred to a fresh 1.7 ml tube. Suspension volumes
were equilibrated with BLGM to a total of 1.4 ml. Recently outdated human erythrocytes
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(American Red Cross, Missoula, MT, Type B-positive) were washed five times in MEM at
4°C and diluted to -lx lO 9 cells/ml. Bartonella and erythrocytes were combined (in three
replicates) to a final MOI of 1:1 in 24 well culture dishes (Falcon-Becton Dickinson,
Lincoln Piark, NJ, Type 3047) and incubated at 30°C for 7.5 hr. Reactions were then
transferred to 1.7 ml tubes, washed twice with intermittent centrifugations of 20 sec at
4000 x g using 1 ml aliquots of MEM at 4°C. After the final wash, reactions were
resuspended in 100 pJ MEM, serially diluted, plated on heart infusion agar, and incubated
at 30°C as described above. To determine the percent adherence, each of the stock
Bartonella suspensions were also serially diluted and plated. CFU counts were made after
12 days growth.

Statistical analysis. The data reported for erythrocyte adherence are the means of three
independent determinations ± standard errors of the means. Percentages of adherent
bacteria are based on numbers of CFU/ml recovered from the adhesion reaction divided by
CFU/ml values initially added to each reaction. Statistical significance of the data
determined by pairwise comparisons using Student’s T test where a value of P <0.05 was
considered significant

RESULTS

Isolation of a highly competent strain. After numerous attempts to disrupt the
flagellin gene in a wild-type B. bacilliformis strain (KC584) failed, we generated a highly
competent strain by curing strain HG584. Grasseschi and Minnick (16) were the first to
successfully transform B. bacilliformis by electroporation-mediated introduction of pEST,
a cosmid containing an RK2 origin of replication and the neomycin phosphotransferase I
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(nptl) gene encoding kanamycin resistance (35). This pEST-containing strain of B .
bacilliformis (HG584) was passaged three times (15 days) in the absence of kanamycin
sulfate. Six randomly selected clones were then subcultured independently and tested for
sensitivity to kanamycin sulfate (25 ng/ml). All six clones exhibited wild-type sensitivities
to kanamycin.
Two of these Karn clones were cultivated and chromosomal DNA was prepared by
the methods of Ausubel etal. (1). DNA hybridization analyses with their chromosomal
DNA using a 32p.radioIabeled pEST probe was negative (data not shown), suggesting that
the pEST cosmid was cured from these two strains. Further analysis of one of these
strains (JB584) by PCR with nptl amplimers verified the absence of pEST (shown in
Figure 2, lane 2). Thus, we were confident that JB584 was no longer kanamycin resistant,
nor was pEST or nptl detectable.
The transformation efficiency of JB584 was subsequently assessed by
electroporation-mediated introduction of pBBRlMCS-2. The plasmid pBBRlMCS-2,
constructed by Kovach et al. (21), contains the REP origin of replication and the nptl
kanamycin resistance cassette. Electrotransformation of pBBRlMCS-2 into JB584
demonstrated a 2000-fold increase in transformation efficiencies compared to KC584 and
was used as the parent strain for further flagellin mutagenesis experimentation.

Cloning of B. bacilliform is fla and construction of suicide and
complementation plasmids. The B. bacilliformis flagellin gene, termed fla was
previously cloned, sequenced, and submitted to GenBank (Accession number L20677).
The fla gene was simultaneously isolated by our laboratory from a X ZAP expression
library (Stratagene Cloning Systems, La Jolla, CA) with rabbit anti-flagellin antiserum. A
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Figure 1. Schematic representation of site-directed f la disruption.
The suicide plasmid pUB508 harbors a 508-bp BgHl/Kpnl internal fragment of the B.
bacilliformis flagellin gene {fla’). The pMB 1 origin of replication on pUB508 is not
recognized by the replicational machinery of B. bacilliformis and thus expression of the
nptl gene can only occur following recombination with the genome. The highly competent
strain, JB584, contains the 1127-bp wild-type fla ORF. Note the position of the flagellin
amplimers in relation to the gene. Electroporation-mediated introduction of pUB508
followed by homologous recombination results in site-directed insertion of pUB508 at the
flagellin gene and generation of strain JB585 {fla-, Kanr). (Figure not drawn to scale.)
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pBK-CMV cosmid clone containing the entire jla gene in a 3800-bp 5a«3AI fragment was
excised from the X clone as per the manufacturer’s instructions (Stratagene) and termed
pAULl. Restriction endonuclease sites from the GenBank sequence, restriction enzyme
mapping, and nucleotide sequencing were used to map the jla gene within pAULl.
pAULl was digested with fft'/idlll, and the 2185-bp fragment containing B.
bacillifomusjla was isolated by agarose gel electrophoresis (1% w/v) and purified by
using a GeneClean II kit (BIO 101). Ligation of this fragment into the //z'/idlll site of
pUC18 (46) resulted in pFLAG3; a source of jla DNA fragments for constructing the
suicide plasmid.
The flagellin targeting suicide plasmid pUB508 was constructed in several steps.
Initially, a ~ 1500-bp Pstl fragment containing the nptl gene was subcloned from pUCK18
(35) into pUC19 resulting in pUCK19. Subsequently, the p-lactamase (bla) gene of
pUCK19 was deleted by removing a l l 18-bp BglII fragment and re-ligating to generate the
suicide plasmid pUB 1. Finally, a KpnllBgRl fragment from pFLAG3 containing a 508-bp
internal portion of the flagellin gene was cloned into pUB 1 resulting in pUB508, the
flagellin targeting suicide plasmid (Fig. 1). Verification of the pUB508 construct was
accomplished by restriction endonuclease analysis and nucleotide sequencing (data not
shown). Previous work had shown that the pMB 1 ori of pUB508 was not recognized by
the replicational machinery of B. bacilliformis (16, 35).
The complementation shuttle plasmid pBBRFLAG was constructed by cloning the
2158-bp //i/rdlll fragment of pAULl into pBBRlMCS. The resulting plasmid,
pBBRFLAG, contains the entire wild-type jla ORF and the REP ori. Ligation was
confirmed by restriction digestion and PCR analyses (data not shown).
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Characterization of fla - mutants by PCR. Eight kanamycin resistant clones were
isolated following electrotransformation of pUB506 into JB584. The frequency of the
homologous recombination event was approximately 1.8xl08. Genomic DNA from two
of these clones was subjected to PCR analysis using three amplimer sets; nptl, jla, and
insertion (refer to Figure 1 for a schematic representation of amplimer target loci). First,
the nptl amplimer set (Nptl 5’/NptI 3’) generated the 983-bp nptl product in the mutant
strains, JB585 and JB586 (Fig. 2, lanes 3 and 4 respectively), and was absent from the
parent strain, JB584 (Fig. 2, lane 2). Thus, the kanamycin resistance in these strains was
not a result of a background mutation. Second, the fla amplimer set (Fla 5’/Fla 1300) was
used to determine whether the insertion of the suicide plasmid occurred at the jla locus.
The parent strain, JB584 generated a 1304-bp product (Fig. 2, lane 5), whereas this
product was absent from the JB585 and JB586 (Fig. 2, lanes 6 and 7, respectively). We
assume that the elongation time for the amplification was not sufficient to generate the large
4.2-kb product expected from insertion of the suicide plasmid. Finally, the insertion
amplimer set (Nptl 5’/Fla 1300) was used to verify the chromosomal junction between nptl
and jla. The -2300-bp product generated from the mutant strains (Fig. 2, lanes 11 and 12)
as well as its absence from JB584 (lane 8) and controls (lanes 9 and 10) confirms the
successful site-directed flagellin disruption scheme illustrated in Figure 1.

Analysis of flagellin synthesis in mutant strains by SDS-PAGE and
im m unoblotting. The PCR analysis in Figure 2 confirmed that the wild-type 1127-bp
B. bacilliformis fla ORF had been insertionally disrupted in strains JB585 and JB586.
SDS-PAGE and immunoblotting were subsequently used to determine the extent of
insertional inactivation on synthesis of the fla gene product in these mutant strains (Fig. 3).
The wild-type 1127-bp B. bacilliformis fla ORF encodes a 42-kDa flagellin polypeptide
(40).
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Figure 2.

Electrophoretic analysis of PCR products derived from B .

b a cilliform is fla - mutants.
PCR products were generated by amplification of chromosomal DNA obtained from parent
and recombinant strains by using three amplimer sets. Amplimer sets designated nptl (Nptl
5’/NptI 3'), fla (Fla 5’/Fla 1300), and insertion (Nptl 5’/Fla 1300) were used to detect the
kanamycin cassette, flagellin gene and insertional junction, respectively. The products
generated from each of the amplifications are indicated on the left The 983-bp nptl product
is present in the mutant strains (lanes 3 and 4) and absent from the parent strain (lane 2).
The 1304-bp fla product is present in the parent strain (lane 5) but is absent in the mutant
strains (lanes 6 and 7). The -2300-bp insertion product is present only in the mutant
strains (lanes 11 and 12) and is absent from the parent strain (lane 8) and controls (lanes 9
and 10). Amplimer sets and the respective DNA templates used in this analysis are as
follows: lane 1 (Nptl 57NptI 3’, Ha 5’/Ha 1300; [no template]), lane 2 (Nptl 57NptI 3 ’;
[JB584]), lane 3 (Nptl 5’/NptI 3 ’; [JB585]), lane 4 (Nptl 57NptI 3 ’; [JB586]), lane 5 (Ha
57H a 1300; [JB584]), lane 6 (Ha 5’/Ha 1300; [JB585]), lane 7 (Ha 5’/Ha 1300;
[JB586]), lane 8 (Nptl 57H a 1300; [JB584]), lane 9 (Nptl 57H a 1300; [pUB508]), lane
10 (Nptl 5’/H a 1300; [JB584 and pUB508]), lane 11 (Nptl 5’/Ha 1300; [JB585]), lane 12
(Nptl 57H a 1300; [JB586]). PCR products were resolved by 1 % agarose gel
electrophoresis and visulaized by ethidium bromide staining. DNA size standards are
indicated to the right Refer to Figure 1 for a schematic representation of amplimer target
sites.
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Figure 3.

Flagellin synthesis in B. bacilliform is fla- mutants by

SDS-PAGE and immunoblotting.
A. Whole cell extracts of parent and Jla- mutant strains were separated on a 12.5%
polyacrylamide-sodium dodecyl sulfate gel, and stained with Coomassie brilliant blue. The
42-kDa flagellin polypeptide, indicated by the arrow, is present in the parent strains KC584
(lane 2) and JB584 (lane 3), but is absent from the two kanamycin-resistant strains JB585
(lane 4) and JB586 (lane 5). B. Corresponding immunoblot incubated with polyclonal
rabbit anti-flagellin antiserum indicating that expression of Jla is completely abolished in
the mutant strains. Lane 1 contains molecular mass standards (in kDa). The 42-kDa
flagellin polypeptide is indicated by the arrow.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

80

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

81

When whole-cell lysates were visualized on Coomassie brilliant blue-stained
SDS-polyacrylamide gels, the flagellin polypeptide was clearly synthesized in strains
KC584 (Fig. 3A, lane 2) and JB584 (lane 3). In contrast, the two Jla- mutants JB585 (Fig.
3A, lane 4) and JB586 (lane 5) lacked the 42-kDa flagellin polypeptide, suggesting that Jla
expression had been disrupted. Immunoblot analysis was subsequently performed using
rabbit polyclonal anti-flagellin antiserum as described previously (40). The immunoblot
confirmed the presence of the flagellin polypeptide in KC584 (Fig. 3B, lane 2) and JB584
(lane 3), and also demonstrated that flagellin synthesis was abolished in both of the mutant
strains JB585 (Fig. 3B, lane 4) and JB586 (lane 5). A truncated flagellin product was not
observed in either strain.

PCR characterization of transcompiemented mutants. In an effort to eventually
satisfy molecular Koch’s postulates (9), we restored the wild-type flagellin phenotype to
one of the mutants by in trans complementation. The plasmid pBBRFLAG contains the
entire wild-type flagellin ORF, a chloramphenicol resistance cassette, and the REP origin
recognized by the replicational machinery of B. bacillijormis. Electrotransformation of
pBBRFLAG into JB585 followed by selection on medium containing 25 pg/ml kanamycin
sulfate and 1 ng/ml chloramphenicol resulted in the isolation of strain JB686. Initial
confirmation of the in trans complementation was accomplished by electrophoretic analysis
of PCR products (Fig. 4). The Jla amplimer set (Ha 5’/R a 1300) was used to detect the
presence of the Jla gene, which was absent in the Jla- mutant strain JB585 (Fig. 4, lane 2),
but was present in both JB584 (lane 1) and the complemented mutant JB686 (lane 3).
Finally, the ~2300-bp product generated by the previously described insertion amplimer set
(Nptl 5’/R a 1300) demonstrates that the original chromosomal mutation was retained by
the complemented mutant JB686 (Rg. 4, lane 4).
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Analysis of flagellin synthesis in the complemented mutant by SDS-PAGE
and immunoblotting. The PCR analysis in Fig. 4 confirmed that the wild-type B .
bacilliformisfla ORF had been successfully reintroduced into the mutant strain JB585
resulting in the complemented mutant strain JB686. SDS-PAGE and immunoblotting were
subsequently used to assay expression of the flagellin gene from the pBBRFLAG plasmid
(Fig. 5). When whole-cell lysates of strain JB686 were visualized on Coomassie brilliant
blue-stained SDS-polyacrylamide gels, the 42-kDa flagellin polypeptide was clearly evident
(Fig. 5A, lane 3) indicating that fla gene expression was occurring from the plasmid locus.
Immunoblot analysis was subsequently performed by reacting whole-cell lysates with
rabbit polyclonal antiserum monospecific to flagellin. The positive
signal confirmed the transcomplementation offla expression from the plasmid in strain
JB686 (Fig. 5B, lane 3).

Phenotypic characterization of strains by transmission electron microscopy.
Transmission electron microscopy was used to visualize the secretion and assembly of the
fiagella in each of the strains (Fig. 6). Micrographs showed that wild-type strain KC584
(Fig. 6A) and competent strain JB584 (Fig. 6B) maintained the normal synthesis, secretion
and assembly of flagellin polypeptides resulting in the wild-type lophotrichous fiagella.
Second, as evidenced by the lack of flagellar filaments, the flagellin ORF of strain JB585
has been insertionally disrupted and the synthesis, secretion and assembly of the flagellin
polypeptide was abolished (Fig. 6C). Finally, the complemented mutant, strain JB686, not
only synthesizes flagellin polypeptides from the plasmid locus, but these polypeptides were
secreted and assembled (Fig. 6D) as in the wild-type strain (Fig. 6A). Therefore, the
fiagella phenotypes of the strains generated were consistent with the genotypes.
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Figure 4.

Detection of in trans complementation by PCR.

The wild-type phenotype was restored to t h e m u t a n t JB585 by transcomplementation
with pBBRFLAG resulting in strain JB686. PCR products were generated by
amplification of chromosomal DNA obtained from parent and recombinant strains by using
the same amplimer sets. Lane 3 indicates that the 1304-bp flagellin product (Jla) has been
complemented in trans in strain JB686. Furthermore, lane 4 demonstrates that the
chromosomal locus of JB686 has retained the original -2300-bp insertion. Amplimer sets
and the respective DNA templates used in this analysis are as follows: lane 1 (Fla 5’/Fla
1300 [JB584]), lane 2 (H a 57Ha 1300 [JB585]), lane 3 (Ha 57Ha 1300 [JB686]), lane 4
(Nptl 57H a 1300 [JB686]). PCR products were resolved by 1 % agarose gel
electrophoresis and visulaized by ethidium bromide staining. DNA size standards are
indicated to the right.
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Figure 5.

Flagellin synthesis in complemented mutants by SDS-PAGE and

immunoblotting.
A. Whole cell extracts of parent, jla- mutant, and complemented strains were separated on
a 12.5% polyacrylamide-sodium dodecyl sulfate gel and stained with Coomassie brilliant
blue. The 42-kDa flagellin polypeptide is present in the parent strain JB584 (lane 1), and is
absent from the kanamycin-resistant Jla- mutant strain JB585 (lane 2). jla expression is
detected in trans from the complementation plasmid pBBRFLAG in strain JB686 (lane 3).
B. Cognate immunoblot reacted with polyclonal rabbit anti-flagellin antiserum indicating
that flagellin synthesis is restored in the complemented strain. Molecular mass standards
(in kDa) are indicated to the left and the 42-kDa flagellin polypeptide is marked by the
arrow.
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Figure 6.

Phenotypic analysis o f generated strains by transmission

electron microscopy.
Transmission electron micrographs were prepared by staining 5-day-old cultures of B .
bacilliformis with 2% uranyl acetate. Flagellin filaments are observed in panel A (wild-type
strain [KC584]) and panel B (competent strain [JB584]) but are absent from the fla- mutant
strain [JB585] in panel C. Expression, secretion and assembly of the fiagella is restored in
the transcomplemented strain [JB686] shown in panel D. (Bars = 0.5 jxm)
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Motility phenotypes of generated strains. Initially, phase contrast microscopy
was used to examine wet-mounts of each of the strains. Using this method, a loss of
motility was observed for strain JB585, whereas strains KC584, JB584 and JB686
appeared to have indistinguishable motility phenotypes. Motility was subsequently
assessed by the ability of the bacterium to spread within a novel Bartonella motility
medium. To develop the assay, we tested a wild-type strain in motility media with agar
concentrations ranging from 0.2 - 0.8 % by stabbing the media with an inoculation needle
from 5-day-old cultures. Incubation for 7 d at 30°C demonstrated that agarose
concentrations of 0.6 and 0.8 % inhibited motility. At agarose concentrations of 0.2 and
0.4 %, however, motility was observed as a uniform halo of growth within the medium
away from the site of inoculation. The four strains used in this study were subsequently
tested in the same way using BartoneUa motility medium containing 0.2 % agar. Multiple
inoculations of each of the strains consistently generated the results shown in Figure 7.
The wild-type strain KC584 (Fig. 7A) and competent strain JB584 (Fig. 7B) possess
identical motility patterns indicating that the highly competent strain does not have an
altered motility due to the transformation-curing process. The mutant strain, JB585 (Fig.
7C), was nonmotile, and did not produce a halo. The complemented mutant, strain JB686
(Fig. 7D), had a halo pattern that was indistinguishable from wild-type. Thus, the
transcomplementation functionedly restored wild-type motility to the mutant

Erythrocyte adherence. Statistical analysis of the four strains tested demonstrate
several significant results, as shown in Figure 8. First, the adhesion potential of the
wild-type strain [KC584] was not significantly different from the transformation competent
strain [JB584] (P=0.66). This suggests that the natural, uncharacterized mutation(s) of
strain JB584 that enable high transformation rates do not affect the virulence. Second,
there was a significant reduction in the adhesion ability of the fla- mutant [JB585] compared
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to both KC584 (P =0.02) and JB584 (P =0.03). This strongly suggests that the flagellum
plays a role in erythrocyte adhesion, and is a true virulence factor, either as a motive force
to promote contacts via hypothesized adhesins such as fimbriae, or alternatively, the
flagellum acts as an adhesin. Third, the complemented strain [JB686], expresses an
intermediate phenotype, one in which there is an apparent increase in recovery compared to
the fla- mutant, but does not fully restore adhesion potential when compared to the
virulence phenotype of KC584 and JB584.

DISCUSSION
In vivo genetic manipulation of a bacterium generally consists of three fundamental
techniques: plasmid transformation, random mutagenesis, and site-directed mutagenesis.
The introduction of a replicative cosmid or plasmid, termed plasmid transformation, was
first demonstrated in Bartonella by electrotransformation of the cosmid pEST into B. (at
that time RochaUmaea) quintana (35). This was subsequently accomplished in B .
bacilliformis by Grasseschi and Minnick (16), and it was reported that B. baciUiformis
recognized the RK2 origin of replication but did not recognize pMB 1, CoIEl, or F origins.
In the course of this study, we determined that the most consistent replicon for high
transformation efficiencies in B. bacilliformis was the broad-host-range vector
pBBRlMCS and it’s derivatives, which contain the REP origin of replication (21,22).
Furthermore, we demonstrate that this vector is a suitable shuttle vector for genetic
experiments involving Bartonella species and E. coli.
The second technique of genetic manipulation is random mutagenesis. Although
there are various methods for accomplishing this procedure, Dehio and Meyer recently
reported successful conjugation between E. coli and B. henselae as a means of plasmid
transformation as well as delivering Tn5 transposons on suicide plasmids for random gene
inactivation (7).
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Figure 7.

Motility of generated strains.

Plates of Bartonella motility medium (supplemented with antibiotics in mutant and
complemented strains) were stabbed with 5-day-old cultures of each strain. The images
shown are looking down on the progressing halo of motile bacteria moving outward from
the central stab. Motility was indistinguishable in all of the strains except the flagellin
mutant (Q , which failed to form the characteristic halo pattern. Photos were taken 7 days
after inoculation: panel A (wild-type strain [KC584]), panel B (competent strain [JB584]),
panel C {/la- mutant [JB585]), panel D (in trans complement [JB686]).
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Figure 8.

Human erythrocyte adhesion.

The data reported for erythrocyte adherence are the means of three independent
determinations ± standard errors of the means. Percent recovery is based on numbers of
CFU/ml recovered from the adhesion reaction divided by CPU/ml values added to each
reaction. The adhesion potential of the wild-type strain [KC584] is not significantly
different from the transformation competent strain [JB584] (P=0.66). Second, there was a
significant reduction in the adhesion ability of the fla- mutant [JB585] compared to both
KC584 (P =0.02) and JB584 (P =0.03). Third, the complemented strain [JB686],
expresses an intermediate phenotype, not significantly different from strain KC584,
JB584, or JB585.
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The third method of genetic manipulation, the focus of this study, is site-directed
mutagenesis, by which various methods can be used to alter or inactivate specific genes.
The most commonly used method employs a suicide plasmid containing an internal portion
of the target gene of interest and an origin of replication that is not recognized by the host
cell DNA replication machinery. Expression of the resistance marker on the suicide
plasmid can only occur after a homologous recombination event integrates the plasmid into
the target site. Furthermore, transcomplementation of the mutation can be accomplished by
reintroducing the wild-type ORF on a replicative plasmid or shuttle vector by plasmid
transformation.
After several frustrating attempts at mutagenizing the flagellin gene using a suicide
plasmid or linear DNA fragments failed, we realized that there were in vivo barriers
impeding transformation in B. bacilliformis. This prompted us to try alternative methods
for alleviating restriction/modification systems as well as biochemical/metabolic
manipulations previously shown to increase the likelihood of homologous recombination.
Although numerous manipulations were attempted, the generation of strain JB584 was a
critical step towards the development of this system. The 2000-fold increase in
transformation efficiencies exhibited by JB584 encouraged the use of this strain as the
parent for successful mutagenesis experiments. However, the possibility exists that the
mutation(s) enabling higher transformation efficiencies may also have an effect on
virulence, although it did not effect adhesion. This possibility will be addressed in
invasion and association assays currently underway.
The lophotrichous flagella of B. bacilliformis and the high degree of motility that it
imparts has been implicated as a virulence determinant in several reports (2,26,40). In
addition, B.clarridgeiae, an etiologic agent of cat-scratch disease, has also been reported as
possessing a lophotrichous flagella (20). A dendrogram analysis of several flagellin
sequences demonstrated that the B. bacilliformis Fla is most similar to Azospirillum
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brasilense, Rhizobium meliloti, Agrobacterium tumefaciens, and Caulobacter crescentus,
forming a cluster distinct from other flagellins (31). Where many bacteria possess
multi-subunit flagella, the mutation data generated in this study suggest that the B .
bacilliformis flagellar filament is composed of multiple polypeptide subunits encoded by a
single flagellin gene. These data conclusively show that inactivation of the single fla gene
completely abolishes the expression of the flagellum and generates a nonmotile and non
flagellated or ‘bald’ strain.
Flagellum-mediated motility is a common phenotype used by many pathogenic
bacteria to colonize or gain access to host tissues or cells (34). Aflagellated or motilityimpaired strains have decreased pathogenicity in numerous bacteria because of impaired
colonization, adherence, or invasion, or by an uncharacterized method. Examples include
Borrelia burgdorferi (38), Campylobacterjejuni (15), Proteus mirabilis (30), Serpulina
hyodysenteriae (37), Agrobacterium tumefaciens (5), Vibrio anguillarum (33), Vibrio
cholerae (36), Salmonella typhi (18), and Helicobacterpylori (8). Several reports have
implicated uncharacterized motility-impaired B. bacilliformis as having a reduced
pathogenicity (2, 26,44). Scherer et al. were able to demonstrate that both erythrocyte
invasion and association were decreased by treating the pathogen with anti-flagellin
antiserum (40). Benson et al. reported the generation of natural nonmotile flagellated
strains that could be maintained in either the motile or nonmotile form (2). However, we
have not observed this phenomenon under the growth conditions described. Finally,
naturally aflagellated B. bacilliformis have not been reported.
The ability to genetically manipulate an organism allows precise identification of the
virulence determinants involved in pathogenicity. This identification must include a set of
principles such as molecular Koch’s postulates wherein alterations in pathogenicity are
directly related to the presence or absence of the gene or gene product in question (9).
These postulates were defined as follows: [1] The phenotype or virulence determinant
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being studied should be associated with pathogenic strains of a species. [2] Specific
inactivation of the gene(s) associated with the virulence trait should lead to a measurable
loss in pathogenicity. [3] Replacement of the mutated gene should lead to restoration of
the pathogenicity. Specific inactivation of the B. bacilliformis flagellin gene showed a
significant loss in erythrocyte adherence compared to controls. Complementation of the
mutation, however, only partially restores the adherence potential. Thus, this is a ‘partial’
demonstration of molecular Koch’s postulates for the flagella. Inconsistent with this partial
adherence phenotype is that the motility phenotype of the complemented strain [JB686] is
indistinguishable from both the wild-type strain [KC584] and the transformation competent
strain [JB584]. At first observation these data suggest that the flagellum is directly
involved in the process of adhesion by acting as an adhesin itself, for motility seems
independent of the extrachromosomal, multicopy nature offla in the complemented strain
[JB686]. However, three alternative explanations exist. First, the data generated in this
study demonstrate that mutagenesis of fla completely abolishes the flagellin motility
phenotype. Perhaps there is more than one component to the flagellum. Providing the fla
ORF extrachromosomally, and at higher copy than wild-type could allosterically inhibit
expression of a second component, which may be involved in erythrocyte adhesion.
Second, the increased copy number or extrachromosomal status of the fla ORF may in
some way alter expression, secretion, or assembly of the flagella such that motility (not
apparent in our motility assay) or adhesins are affected. Third, the adherence assay was
performed in the absence of antibiotic supplements, whereas the motility assay included the
supplements. Perhaps the expression of the plasmid localized fla was diminished over the
7.5 hour adherence assay in a mechanism similar to the plasmid purge of a curing. It
would be interesting to construct a fla+, motility- strain and include it in future studies.
As mentioned above, Bartonella have been shown to adhere to and invade both
erythrocytes and endothelial cells, leaving several questions concerning the pathogenicity of
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the flagella unanswered. This research has generated a system of genetic manipulation that
will enable mutagenesis and complementation of other putative virulence determinants, as
well as a method to determine the role of these factors in relationship to adherence.
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CHAPTER FOUR
Mutations in Bartonella bacilliform is gyrB

confer resistance to

coumermycin A |.
James M. Battisti, Laura S. Smitherman, D. Scott Samuels and Michael F. Minnick.
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ABSTRACT

This study describes the first isolation and characterization of background mutants
confemng natural resistance to an antibiotic for any Bartonella species. The B .
bacilliformis gene encoding the B subunit of DNA gyrase, gyrB, was cloned and
sequenced from overlapping phagemid clones derived from lambda genomic libraries by
using radiolabeled probes to highly conserved regions of the gene. The gyrB ORF is
2079-bp and encodes a deduced amino acid sequence of 692 residues corresponding to a
predicted protein of -77.5 kDa. Sequence alignment indicates that B. bacilliformis GyrB
is most similar to the GyrB protein from Bacillus subtilis (40.1 % amino acid sequence
identity), and that it contains the longest N-terminal tail (52 residues) of any GyrB
characterized to date; the only other tail of similar length (50 residues) occurs in
Mycobacterium tuberculosis GyrB. The cloned B. bacilliformis gyrB was expressed in an
E. coli -S30 cell-free extract, and was able to functionally complement an E. coli couR-ts
gyrB mutant (strain N4177). We isolated and characterized background mutants of B .
bacilliformis resistant to coumermycin A i, an antibiotic that targets GyrB. Mutants were
selected in the presence of 0.1 pg/ml coumermycin A i , and occurred at a frequency of ~6 x
10-9. Sequence analysis of gyrB from 12 couR mutants of B. bacilliformis identified
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single nucleotide transitions at three separate loci in the ORF. The predicted amino acid
substitutions resulting from these transitions are Gly 124 -* Ser, Argl84 -* Gin, and
Thr214 —* Ala or Thr214 -» lie, which are analogous to mutated residues found in
previously-characterized resistant gyrB genes from Borrelia burgdorferi, Escherichia coli,
Staphylococcus aureus, and Haloferax. MIC analysis of the four types of couR mutants
demonstrated that they are three to five times more resistant to coumermycin A i than the
wild-type parental strain.

INTRODUCTION
Recent taxonomic re-classifications involving bacteria formerly constituting the
Rochalimaea and Grahamella genera have rapidly expanded the number of species in the
Bartonella genera (6,9, 11,30,56). Of these 12 species, five are presently considered to
be etiologic agents of emerging infectious disease in humans including Bartonella
bacilliformis, B. clarridgeiae (30), B. elizabethae, B. henselae, and B. quintana (for recent
reviews see 29 and 40). Hemotrophy and arthropod vector-mediated transmission are
common parasitic strategies utilized by these small, gram negative, facultatively intracellular
pathogens.
Bartonella bacilliformis is the etiologic agent of a unique biphasic disease that is
endemic to South America, termed Oroya fever (1,31). This geographic restriction
coincides with the distribution of the sandfly vectors (Phlebotomus and Lutzomyia ssp.)
(1, 18, 21,31,55). Humans are the only known reservoir, and in some areas of Peru over
60% of the asymptomatic population is seropositive for B. bacilliformis (28) and 5-10%
are active carriers (31). Within four weeks following infection, the primary phase of the
disease presents with an acute fulminating hemolytic anemia that has been reported to have
as high as an 88% fatality rate in the absence of antibiotic therapy (20). During this
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primary (hematic) phase nearly every erythrocyte is parasitized and upwards of 80% are
lysed (26). Following resolution of the primary phase, the chronic secondary (tissue)
phase, termed verruga peruana, presents with cutaneous lesions on the skin of the head and
extremities which may occur for months to years (1,18). Verruga peruana are clinically
indistinguishable from the cutaneous lesions of bacillary angiomatosis (BA), caused by B.
quinlana and B. henselae (29).
Due to the lack of a system for site-specific genetic manipulation, few reports have
been published concerning the molecular mechanisms involved in the pathogenesis,
growth, and antibiotic resistance of B. bacilliformis (4, 16, 17, 31, 34, 36, 38, 41, 49, 54,
58). Therefore, we initially address this problem by molecularly characterizing the
pathogen's gyrB gene. DNA gyrase is the bacterial type II topoisomerase responsible for
introducing negative supercoiling into DNA (reviewed in 44 and 24) and it is the target of
several types of antimicrobial agents. The holoenzyme is an A2B2 complex encoded by the
gyrA and gyrB genes; the A subunit is responsible for DNA breakage and reunion,
whereas the B subunit harbors the ATP binding site. The coumarin antibiotics
coumermycin A i, novobiocin, and chlorobiocin impede DNA replication by inhibiting the
ATP binding and hydrolysis catalyzed by GyrB (35). Several reports have demonstrated
that single point mutations in the gyrB gene confer resistance to coumarin antibiotics (12,
14, 23,43,46,51) providing a locus and selectable phenotype for allelic exchange
experiments.
In this study, we describe the isolation and characterization of the first background
mutants of any Bartonella species, as well as the first characterization of an antibiotic
resistance mutant. Analysis of coumermycin A i-resistant mutants revealed single
nucleotide lesions corresponding to specific amino acid substitutions in the N-terminal
domain of GyrB. These mutations confer an approximately 5-fold increase in
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coumermycin A i-MIC relative to wild-type. In addition, we show that the B. bacilliformis
gyrB can functionally complement an E. coli gyrB mutant Finally, we discuss the position
of the amino acid substitutions as they relate to recently solved high-resolution crystal
structures and enzyme function (33, S7).

MATERIALS AND METHODS
Bacterial strains and culture conditions. Escherichia coli strains used for
propagation of cloned genes were grown overnight at 37°C in Luria-Bertani (LB) medium
with standard antibiotic supplements when required (13). B. baciUiformis was routinely
grown on heart infusion agar (Difco, Detroit, Mich.) supplemented with 5% defibrinated
sheep erythrocytes and 2.5% filter-sterilized sheep serum (Quad Five, Ryegate, Mont.) at
30°C in a water-saturated atmosphere. Wild-type B. bacilliformis cultures were usually
observed 3 days after inoculation and cells were harvested after 5 days of growth.
To isolate coumermycin A i -resistant mutants, suspensions of 5-day-old cultures of
B. bacilliformis KC583 were plated on heart infusion agar supplemented with 5%
erythrocytes and 0.1 pg/ml coumermycin Ai (Sigma Chemical Co., St. Louis, Mo.).
Coumermycin A i-resistant mutants were usually observed after 5 days growth and
harvested after 7 days. Resistant colonies were picked with an inoculation loop and
resuspended in 150 pi of heart infusion broth. Subsequent culture of the resistant mutants
was achieved on heart infusion agar (with 5% erythrocytes) containing 0.04 pg/ml
coumermycin A ^ Strains of B. bacilliformis and E. coli used or generated in this study are
summarized in Table 1.
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pGYRB3

pGYRB2

Plasmids
pBK-CMV
pCR2.1-TOPO
pGYRBl

E. coli
HB101
TOPIOF’
N99
N4177

Phagemid cloning vector
Cloning vector
pBK-CMV recombinant containing 5 ’ portion of B. bacilliformis gyrB
in a ~2000-bp Sau3AI fragment. Derived from X.-ZAP library.
pBK-CMV recombinant with a ~ 13-kb SocI fragment containing the
B. bacilliformis gyrB. Derived from \-G E M 11 library.
pCR2.1-TOPO recombinant containing entire gyrB gene in a 2 4 10-bp
damHI fragment. Derived from TA cloning strategy.

Host strain used for cloning
TOPO TA Cloning Kit host strain
Complementation analysis strA, galK
Isogenic to N99 excepl&yrfi221(couR), gyrB203(ts)

This study

This study

(Stratagene Cloning, 1993 #172)
(Invitrogen, 1997 #177]
This study

Promega/[Boyer, 1969 #175]
(Invitrogen, 1997 #177]
(M en/el, 1983 #174]
[Menzel, 1983 #174]

This study

KC583 GyrB, jhr 2| 4

CR5, 10
lie) couR

This study
This study

KC583 GyrB,Thr 214 _ Ala) couR

CR4, 7. 11, 12

(Brenner, 1991 #54J
This study

Source/Reference

CR3

Relevant characteristics

Wild-type strain
KC583 GyrB(0|y 124 - Ser) couR
KC583 GyrB(Afg 184 ^ G|n) couR

Strains
B. bacilliformis
KC583
C R 1 .2 . 6, 8 , 9

Strain or plasmid

TABI.H 1. Bacterial strains and plasmids used in this study

8

109

Preparation and manipulation of DNA. Chromosomal DNA from B. bacilliformis
for use in DNA hybridization or PCR analyses was prepared using CTAB
(hexadecyltrimethyl ammonium bromide) by the methods of Ausubel et al. (3). Plasmid
DNA extraction and isolation from E. coli for cloning were performed by the alkaline lysis
procedure of Bimboim and Doly (5), and plasmid preparations for sequencing were made
with either a Midi-Prep kit (Qiagen, Chatsworth, Calif.) or a Perfect Prep kit (5 PRIME-3
PRIME, Boulder, Colo.) as per the manufacturer’s instructions. Cloning of individual
DNA fragments was accomplished by two distinct methods. First, both X-ZAP Express
(Stratagene Cloning Systems, La Jolla, Calif.) and X-GEM 11 (Promega, Madison, Wise.)
genomic cloning systems were used as per the manufacturer’s recommendations to obtain
phagemid clones containing the B. bacilliformis gyrB gene for sequence analysis. Second,
the TOPO TA Cloning Kit (Invitrogen, Carlsbad, Calif.) was used as per the
manufacturer’s instructions to obtain a plasmid clone containing the entire wild-type gyrB
ORF for gene expression and functional complementation analyses. When required, DNA
was purified from ethidium bromide-stained agarose gels or PCR reactions with either a
GeneClean kit (Bio 101, Inc, La Jolla, Calif.) or by a QlAquick kit (Qiagen, Chatsworth,
Calif.). Plasmids and recombinants used or constructed in this study are summarized in
Table 1.

PCR and oligonucleotides. PCR amplifications were achieved by using a GeneAmp
2400 Thermocycler (Perkin Elmer, Norwalk, CT) following procedures developed by
Mullis et al. (42). Reaction mixtures contained lOmM Tris-HCl, pH 8.3, 50 mM KC1,200
pM each deoxynucleotide triphosphate, 4 mM MgCI2, 2.5 U AmpliTaq DNA polymerase
(Roche Molecular Systems, Branchburg, N.J.), 1-100 ng Template DNA, and 0.1 pg of
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each primer. The reaction proceeded for 30 cycles of 1 min at 94°C, 1 min at 50-60°C
(depending on calculated primer melting temperature), and 1 min at 72°C with an initial 5
min denaturation at 94° C and a final 7 min extension at 72°C. Single-stranded degenerate
oligonucleotide primers (based on regions of conserved homology (25)) GYRB5
(5’-AARMGNCCNGGNATGTAY ATHGG-3’) and GYRB3
(5’-CCNACNCCRTGNARNCCNCC-3’), were synthesized by Gibco-BRL.
Single-stranded oligonucleotide primers specific for the B. bacilliformis gyrB gene;
GYRB-F (5 ’-CGCGGAT CCCT GCGGAATAA CAAAT CAT GGT G-3 ’), GYRB-R
(5’-CGCGGAT CCT ATCGATAAAACGAT CCAT CT GGC-3 ’), LESION-F
(5’-GCTGATTTGATTGATATAACATTGG-3 ’), and LESION-R
(5’-TATAAA n l HTCTGGGTCAAAAGC-3’) were synthesized by the University of
Montana Murdock Molecular Biology Facility.

DNA H ybridization analysis.

Total DNA from B. bacilliformis strains KC583,

KC584, and E. coli strain H B 101 was isolated, digested to completion with Ba/nHI, and
then separated on an ethidium bromide-stained 1% agarose (wt/vol) gel. The gel was then
blotted onto a nitrocellulose membrane (0.45-pm-pore-size; Schleicher & Schuell, Keene,
N.H.) by the method of Southern (50) and baked for 1 h at 80°C. The 2410-bp fragment
used as the probe in this analysis was derived by PCR amplification using the amplimer set
GYRB-F/GYRB-R and B. bacilliformis KC583 as template DNA. This 2410-bp PCR
fragment was subsequently labeled by random primer extension (15) with the Klenow
fragment of E. coli polymerase I (Gibco-BRL) and [a-^PJdC T P (New England Nuclear,
Boston, Mass.). The blot was probed overnight at 50°C with the 32p-iabeled 2410-bp
PCR fragment and washed as previously described (39). The blot was subsequently
exposed for 1 h to X-ray film (X-Omat XAR-5; Eastman Kodak Co., Rochester, N.Y.) to
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visualize hybridized DNA fragments.
DNA hybridization was also used for probing two separate X.-genomic libraries to
clone and sequence the gyrB gene. In these experiments, either the 300-bp PCR product
derived from the degenerate amplimer set GYRB5/GYRB3 or the internal 1101-bp Hindlll
fragment were labeled by random primer extension. The X-plaques were transferred to
nitrocellulose filters and were probed overnight at 50°C with the corresponding 32p-iabeled
fragment and washed as previously described (39). The blot was subsequently exposed
for 1 h to X-ray film (X-Omat XAR-5) to visualize potential X.-recombinants.

In vitro transcription/translation.

Expression of gyrB was done using an £.

coli-S30 cell-free in vitro transcription/translation (IV TI ) system per the manufacturer’s
instructions (Promega). In brief, purified plasmid DNA was incubated with 10.0 /<Ci
[35S] methionine and the constituents of the IVTT kit for 2 h at 37°C. The reactions were
stopped by placing the tubes in an ice bath for 5 min. An equal volume of Laemmli sample
buffer (LSB)(32) was added and the sample was heated to 100°C for 10 min. After
centrifuging for 1 min at 16,000 x g, a 15 /d aliquot was subjected to SDS-PAGE (12.5%,
w/v acrylamide) analysis. The gel was vacuum-dried and subjected to autoradiography
overnight (X-Omat XAR-5) to visualize labeled proteins.

In vivo complementation analysis. A plasmid containing the cloned gyrB
(pGYRB3) and the respective cloning vector (pCR2.1-TOPO) were isolated and purified.
These plasmids were separately introduced into strains N99 and N4177 by modifying the
transformation procedure of Chung etal.( 10) such that the culture temperature of N99 and
N4177 was held below 30’C throughout the transformation procedure. Transformed
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clones of N99 or N4177 containing either pGYRB3 or pCR2.1-TOPO plasmids were
selected by incubation at 30°C for 16 h in the presence of 100 pg/ml ampicillin.
Immediately thereafter, clones of each of the four transformants (N99[pCR2.1-TOPO],
N99[pGYRB3], N4177[pCR2.1-TOPO], and N4177[pGYRB3]) were simultaneously
replica-plated onto LB (supplemented with 100 pg/ml ampicillin), and incubated at either
30°C (permissive temperature) or 42°C (restrictive temperature) for 20 h. Both E. coli
host strains (N99 and N4177) were replica-plated onto LB and LB 100 pg/ml ampicillin
simultaneously for additional positive and negative controls, respectively. Replica-plated
clones were scored after 20 h growth by estimating relative colony size.

Antibiotic susceptibility testing.

MIC’s were determined by two methods. First,

determination of wild-type coumermycin A i MIC was achieved by plating 100 pi
Bartonella suspensions containing 105 CFU/ml on heart infusion agar supplemented with
5% erythrocytes and coumermycin Ai concentrations ranging from 0.01 to 1.0 pg/ml.
Second, determination of MIC’s for couR mutants was accomplished by an agar dilution
technique previously described for Bartonella (34). Briefly, resistant strains were
harvested after 5 days of incubation, washed and resuspended in phosphate buffered saline
(pH 7.5). The suspensions were then equilibrated to a McFarland 0.5 standard at OD60oTen microliter aliquots were applied to heart infusion agar supplemented with 5%
erythrocytes and coumermycin Ai concentrations of 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8,
0.9, and 1.0 pg/ml. The MIC is defined as the concentration of coumermycin A i at which
no growth is detected following 7 d of routine incubation. MIC’s were obtained by three
independent determinations.
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Nucleotide sequencing and computer analysis. The inserts of overlapping clones
derived from X-ZAP Express (pGYRB 1) and X-GEM 11 (pGYRB2) genomic libraries
were sequenced separately to obtain the nucleotide sequence for the entire gyrB gene.
Double-stranded phagemid or lambda phage DNA templates were prepared using a Plasmid
Midi-Kit (Qiagen) or Lambda Kit (Qiagen), respectively, as per the manufacturer’s
instructions. These templates were then primed with M13 universal forward or reverse
primers, or alternatively with synthetic oligonucleotides prepared with an Applied
Biosystems (Foster City, Calif.) DNA synthesizer, Model 394. The nucleotide sequences
for both DNA strands of the gyrB gene were then determined by the dideoxy
chain-termination method of Sanger et a/.(48) using a Taq DyeDeoxy Terminator Cycle
Sequencing Kit as per the manufacturers instructions (Applied Biosystems). Sequencing
was done on an Applied Biosystems Automated DNA Sequencer, Model 373A. Sequence
data were compiled and analyzed using PC/GENE 6.8 software (Intelligenetics, Mountain
View, Calif.) for restriction site determination and ORF identification; BLAST (2) for
database searches; CLUSTAL-W 1.6 (53) for multiple sequence alignments; and
BOXSHADE 3.2 (22) for sequence alignment formatting.

Nucleotide sequence accession number. The GenBank accession number for the
Bartonella bacilliformis gyrB nucleotide sequence is U82225.

R ESU LTS
Cloning the g y rB gene. Two clones were required for sequence analysis of this gene.
A positive plaque with the cloned B. bacilliformis gyrB gene was isolated from a X-ZAP
Express library (Stratagene) by probing with a [a-32P]dCTP-labeled 300-bp PCR product
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generated from B. bacilliformis KC583 template DNA using the degenerate oligonucleotide
primers GYRB5 and GYRB3. A pBK-CMV phagemid clone was excised from the X-ZAP
Express clone and termed pGYRB 1. Nucleotide sequence analysis revealed that only the
5’ portion ( 1094-bp) of the gyrB gene was present in the ~2000-bp Sau3Al insert of
pGYRB 1.
Toobtain the remainder of the sequence for gyrB, the 1101-bp Hindlll fragment of
pGYRB 1 containing the 5’ portion of the gyrB gene was labeled by random primer
extension and used to probe a X-GEM 11 genomic library (Promega) in hopes of obtaining
a X clone with a larger insert containing the entire gyrB gene. A second X clone was
identified and found to contain the entire gyrB gene in a ~13-kbp Sacl fragment by DNA
hybridization. The Sacl fragment was excised and cloned into pBK-CMV to generate
pGYRB2. The insert in pGYRB2 was used to complete the nucleotide sequencing of the
wild-type B. bacilliformis gyrB gene.
The complete gyrB gene (2410-bp) was amplified from B. bacilliformis KC583
DNA using the amplimer set GYRB-F/GYRB-R and cloned into pCR2.1-TOPO. This
gyrB recombinant was designated pGYRB3.

Nucleotide sequence of the g y rB gene. The nucleotide sequence of the wild-type
(coumermycin Ai-sensitive) B. bacilliformis gyrB gene was determined from both DNA
strands and is presented in Figure 1. Computer-assisted analysis of the gyrB gene showed
a 2079-bp ORF. This ORF is characterized by a common initiation codon, ATG, that is
preceded by putative -35 (TTCAAA) and -10 (GATAAT) consensus regulatory elements
and a potential ribosomal binding site (AGTA) (Fig. 1).
Further analysis of the ORF indicated that the encoded protein had a deduced length
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Figure 1. Nucleotide and predicted amino acid sequence of B .b a c illifo rm is
g y r B . The nucleotide sequence of a 2250-bp fragment containing the wild-type
coumermycin Ai-sensitive B. bacilliformis gyrB is shown. Nucleotides within the
2079-bp ORF are given in uppercase letters and the deduced 692 residue amino acid
sequence is shown below each corresponding codon. Putative consensus regulatory
elements are indicated (-35, -10, Ribosomal Binding Site). The stop codon is marked with
an asterisk. The three codons (and their corresponding amino acids) in which single
nucleotide substitutions were found resulting in coumermycin A i resistance are boxed.
The unusually long 52 residue N-terminus is typed in boldface. The predicted molecular
mass of the mature protein is 77.5 kDa. The GenBank accession number for the gyrB gene
is U82225.
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Figure 2.

Multiple Alignment of B. bacilliform is GyrB with B. subtilis E.

co li and M. tuberculosis G yrB. Multiple alignment of B. bacilliformis GyrB (Barba)
with B. subtilis GyrB (Bacsu), E. coli GyrB (Ecoli), and M. tuberculosis (Myctb)
generated with CLUSTAL-W 1.6 (171) and formatted with BOXSHADE3.21 (76).
Identical amino acid residues are shaded black, conserved residues noted in grey, and
introduced gaps shown by dots. Note the unusual 53 residue N-terminal extension that is
similar in length to the N-terminus of M. tuberculosis GyrB. The first universally
conserved residue (E. coli of Tyr5) is indicated by the arrowhead. GenBank accession
numbers for these sequences are U82225 (Barba GyrB), D26185 (Bacsu GyrB),
AE000447 (Ecoli GyrB) and X78888 (Myctu GyrB).
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of 692 amino acid residues and a predicted molecular mass of approximately 77.5-kDa.
BLAST (2) homology searches indicate that B. bacilliformis GyrB is most similar to
Bacillus subtilis GyrB with an amino acid sequence identity of 40.1%. The B .
bacilliformis subunit shares 34.1% identity with E. coli GyrB. Alignment of the deduced
amino acid sequence from B. bacilliformis gyrB with the known amino acid sequences of
GyrB’s from E. coli, B. subtilis, ansi Mycobacterium tuberculosis (using Clustal-W 1.6)
indicates multiple areas of strong homology (Fig. 2) and reveals that the B. bacilliformis
GyrB has an unusually long N-terminus. Sequence analysis of ~600-bp of flanking
sequence indicate a possible gene upstream of gyrB with homology to lipoate-protein
ligase B, whereas 3 ’ flanking sequence produces no areas of strong homology to database
sequences (data not shown).

DNA hybridization analysis. In order to verify that the gyrfi-containing fragment
was of Bartonella origin, DNA hybridization analysis was done using BamHI-digested
DNA from B. bacilliformis strains KC583 and KC584 and from E. coli HB101. As
shown in Figure 3B, Southern blots probed at high stringency (7% mismatch) with a
32P-labeled 2410-bp PCR fragment derived from B. bacilliformis KC583 template (using
amplimers GYRB-F and GYRB-R) clearly demonstrated single hybridization bands from
both strains of B. bacilliformis (Fig. 3B, lanes 3 and 4). No signal was observed in
BamHI-digested E.coli HB 101 DNA (Fig. 3, lane 2). In addition, the G+C content of the
ORF (38.4 %) is in good agreement with the overall 39 mol % G+C of B. bacilliformis
( 8 ).

In vitro expression of g y rB . To determine if E. coli transcriptional/translational
machinery would express the cloned B. bacilliformis gyrB, an E.coli -S30 cell-free DNA
expression kit (Promega) was used to produce polypeptides in vitro. SDS-PAGE analysis
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Figure 3.

Detection of the gyrB gene in the B. bacilliform is chromosome

by DNA hybridization. (A) Ethidium bromide-stained agarose gel (1%, w/v)
containing: 1, X. f/mdlll size standards; 2, BamHl-digested chromosomal DNA of E. coli
strain HB 101; 3, BamHl-digested chromosomal DNA of B. bacilliformis strain KC583; 4,
BamHl-digested chromosomal DNA of B. bacilliformis strain KC584; 5, no DNA; 6,
2410-bp PCR fragment containing the entire B. bacilliformis gyrB ORF. (B) The
corresponding autoradiograph following DNA hybridization with the described 2410-bp
PCR fragment labeled with 32p-dCTP. The lanes are the same as in (A) Note the
hybridization signal in both B. bacilliformis strains (lanes 3 and 4).
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of proteins expressed from pGYRB3 revealed a protein product consistent with the
predicted molecular mass for GyrB of 77.5-kDa that was not expressed from the
pCR2.1-TOPO control by this system (data not shown). The 77.5-kDa protein was the
largest protein encoded although additional insert-specific protein bands of approximately
68,65, 52 and 38-kDa were observed and may have been produced by the E.coli-S30
extract from anomalous ORF’s on the non-coding strand of pGYRB3 or may be
degradation products.

Functional complementation analysis. Since the S30 extract expressed the cloned
gyrB, An isogenic pair of E. coli strains first described by Menzel and Gellert (37) was
used to evaluate the in vivo function of the cloned B. bacilliformis gyrB. E. coli strain N99
carries a wild-type gyrB, and strain N4177 has two gyrB mutations, which together confer
a coumermycin A i -resistant (couR) and temperature sensitive (ts) phenotype. Growth of
strain N4177 is permissive at 30°C but is restricted at 42°C unless a functional gyrB is
supplied in trans to complement the couR-ts mutation. Therefore, we wanted to determine
whether B. bacilliformis gyrB could functionally complement strain N4177. To address
this question the B. bacilliformis gyrB recombinant pGYRB3 was introduced into strains
N99 and N4177, selected at 30°C and subsequently replica-plated and separately incubated
at both permissive (30°C) and restrictive (42°C) temperatures. The B. bacilliformis gyrB
recombinant, pGYRB3, was shown to increase the growth rate of strain N4177 at42°C by
approximately 3-fold relative to negative controls (Table 3). The presence of plasmidsor
varied incubation temperature did not affect the relative growth rates of host strain N99.
The pattern of growth for this analysis was consistent and reproducible, and shows that B .
bacilliformis gyrB can functionally complement the counts mutation of E. coli strain
N4177.
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Isolation o f coumermycin At -resistant mutants. Background coumermycin
A 1-resistant mutants were observed 7 days after inoculation and occurred at a frequency of
~6xl0-9 when selected in the presence of 0.1 pg/ml coumermycin A j. After initial
selection, mutant strains were cultured on heart infusion agar supplemented with 0.04
Hg/ml coumermycin Ai- A total of twelve B. bacilliformis KC583 coumermycin-resistant
(CR) mutants were selected in this manner and designated CR1 through CR12 (Table 1).
In the absence of coumermycin-Ai, the growth rate and gross morphology of the CR
colonies were indistinguishable from wild-type strains.

Coumermycin At resistance is correlated with mutations in the gyrB g en e.
Genomic DNA was isolated from wild-type B. baciUiformis KC583 and the 12
coumermycin A r resistant mutants. The region of the gyrB gene encoding the N-terminal
domain was amplified by PCR with LESION-F and LESION-R primers and subsequently
sequenced with the LESION-F primer. Further analysis of these sequences revealed
single nucleotide transitions at three separate loci that resulted in four distinct amino acid
substituhons. First, in five of the 12 coumermycin A i-resistant strains (CR1, CR2, CR6,
CR8, and CR9), identical G-to-A transitions at base 370 of the 2079-bp ORF resulted in a
deduced Glyl24 -*■ Ser substitution for all 5 strains. Second, four of the 12 resistant
strains (CR4, CR7, CR11, and CR12) carried a G-to-A transition at base 550 that resulted
in a deduced Argl84 -* Gin substitution. The third loci at which lesions were detected
occurred in the Thr 214 codon, in which two different transitions were observed with two
distinct deduced substitutions; ACA-to-GCA resulted in aThr214 —*Ala substitution
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Glutamine

Alanine
Isoleucine

Arginine 184

Threonine 214

Threonine 214

0.2

0.2
0.3

8.3
16.6

0.2

33.3

41.6

Frequency" MICfc*c

B. burgdorferi Thrl62 - lie 147]
S. aureus Thrl73 -> Asn (51]

E. coli Argl36-» Leu, Cys, His, Ser [12], (14]
B. burgdorferi Argl33 -* Gly, lie (46]
S. aureus Argl44 -* lie [51]
Haloferax Argl37 -* His (23]

B. burgdorferi Gly 74 -* Ser 147]
S. aureus Gly85 -* Ser (511

Homologous GyrB lesions

0 The frequency is expressed as a percentage of the 12 total isolates.
b The MIC is defined as the concentration in pg/ml which completely inhibited growth.
The MIC for wild-type KC 583 was 0.06 pg/ml.
c The MIC was determined for CR3, CR4, CR5, and CR9, which are representative of
each of the mutant types.

Serine

Substitution

Glycine 124

Residue

TABLE 2. Genotypic and phenotypic analysis of B. bacilliformis gyrB mutants

TABLE3. Complementation with B. bacilliformis gyrB
E. coli
Strain

N99
N4177

Growth at 42°C<With the following plasmids:
pCR2.1-TOPO
pGYRB3
none
+++b
+ /-c

+++

+++

+ /-

++ +

a Restrictive temperature for N4177 [37]
b Robust growth
c Slight growth
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(CR3), whereas ACA-to-ATA resulted in aThr214 —►lie substitution (CR5, CR10). These
data demonstrate that background coumermycin A i - resistant mutants are correlated with
specific and localized lesions in the gyrB gene. Table 2 summarizes several genotypic and
phenotypic attributes of the coumermycin A i resistant (CR) strains.

In vitro coumermycin Ai susceptibilities.

We assessed the antibiotic susceptibility

of wild-type B. bacilliformis KC583 to coumermycin A! by using agar dilution techniques.
At concentrations above 0.03 fig/ml, growth rates were noticeably decreased and above
0.06 pg/ml growth appeared to be completely inhibited. Thus, the MIC for KC583 was
determined to be 0.06 pg/ml. One representative of each of the four different gyrB mutant
types was assayed for coumermycin A! susceptibility. MIC’s for mutant strains CR3,
CR4, and CR9 were 0.2 pg/ml, whereas CR5 demonstrated a slightly higher level of
resistance with a MIC of 0.3 p-g/ml (Table 2).

D ISC U SSIO N
We have described the first isolation and molecular characterization of background
mutant strains conferring natural resistance to an antibiotic for any Bartonella species.
Generation of the mutant strains was accomplished by exposure to inhibitory (0.1 fig/ml)
levels of the DNA gyrase inhibitor coumermycin A i , and occurred at a frequency of
-6x10-9. Based upon amino acid sequence alignments B. bacilliformis GyrB belongs to
the shorter 650-amino-acid size class represented by homologues of enzymes from B .
subtilis, Mycoplasma pneumoniae, Staphylococcus aureus, Borrelia burgdorferi, and
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Haloferax (24). In the larger 800-amino-acid size class, represented by E. co li, an extra
150-amino acid block is found in the C-terminal domain of the protein (24) (Fig. 2). The
commonly recognized ATP binding motif of GXXGXG is found at positions 162 to 167 of
B. bacilliformis GyrB, corresponding to positions 114 to 119 of E. coli GyrB.
The structure of the B. bacilliformis GyrB is unusual in two ways. First, when
analyzing GyrB’s sequenced to date, the first N-terminal amino acid that demonstrates
universal conservation throughout bacteria is aTyr residue represented by E. coli Tyr5,
corresponding toTyr53 of B. bacilliformis (Fig. 2). The side chain of Tyr5 hydrogen
bonds to the bound ATP analog (57). The number of amino acids preceding this conserved
Tyr is less than 13 residues for nearly all bacteria examined to date. B. bacilliformis GyrB
is unusual in this respect in that 52 amino acid residues precede the E. coli Tyr5 homolog,
making it the longest N-terminal extension reported to date. Only M. tuberculosis has an
N-terminal extension of this magnitude, with 50 amino acids (Fig. 2); however, the two
extensions are not homologous. The crystal structure of E. coli GyrB N-terminal domain
complexed with a non-hydrolyzable ATP analog shows that the N-terminal 13 residues
form a protrusion that interacts with the other GyrB protomer (57). This interaction
stabilizes the dimer interface and forms part of the ATP binding site (57). However, the
N-terminus is apparently not ordered in the co-crystal structure with the coumarin inhibitor
novobiocin (33). The function of the unusually long N-terminal extensions of M.
tuberculosis and B. bacilliformis GyrB’s is intriguing and remains to be determined. A
second primary structural feature of B. bacilliformis GyrB that we have noted is Glul28
(E. coli Gly81 equivalent). In all wild-type GyrB’s reported thus far, this residue is either
glycine or aspartate, with the exception of the Mycobacteria, which have alanine or
glutamate at this position. In this respect, B. bacilliformis GyrB is also more similar to the
Mycobacteria GyrB. This position is one of three loci that is mutated in a
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novobiocin-resistant Haloferax (Asp82 -* Gly) (23), although it is distant from the
coumann binding site (33). Although both B. bacilliformis and M. tuberculosis are
slow-growing bacteria and have several similar GyrB structural features, the effect of these
properties on interactions with ATP or coumarins is unknown.
The mechanism of coumermycin A i-resistance in B. bacilliformis mutants was
identified by sequencing PCR fragments generated with primers amplifying the portion of
the gyrB gene that encodes the N-terminal domain. We have isolated 12 coumermycin
Ai-resistant mutants and have identified single nucleotide transitions at three separate loci
resulting in single amino acid substitutions in the N-terminal domain of the GyrB protein.
Lesions detected in the resistant B. bacilliformis gyrB genes are analogous in location and
residue substitution to previously characterized resistant gyrB genes (12, 14, 23, 46, 47,
51). The crystal structure has revealed important interactions for each of the lesion sites.
First, the side group of the E. coli Argl36 residue (B. bacilliformis Argl84) makes
critical hydrogen bonds with the coumarins and with E. coli Tyr5 (B. bacilliformis Tyr53)
on the other protomer (which is involved in ATP binding) (33). The second and third
residues associated with coumarin resistance, E. coli Gly77 (B. bacilliformis Gly 124) and
E. coli Thrl65 (B. bacilliformis Thr214), specifically interact with each other as well as
stabilize mteracuons with ATP and coumarins (33).
These data demonstrate that the B. bacilliformis DNA gyrase B protein is a target
for coumarin antibiotics. At a MIC of 0.06 pg/ml, wild-type B. bacilliformis was shown
to be more susceptible to growth inhibition by coumermycin A! than almost all other
bacteria tested (59), and is 250 times more susceptible than E. coli (19). These data are
consistent with the finding that Bartonella are extremely susceptible to a variety of
antibacterial agents in vitro (34). The mutant strains demonstrated a ~5 fold increase in
resistance levels. GyrB mutants represented by strains CR3, CR4, and CR9 were
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determined to have a MIC of 0.2 (ig/ml, whereas the MIC of CR5 was 0.3 fig/ml. This
suggests that a Thr214 -* lie substitution confers a higher level of resistance than Thr214
-* Ala, Gly 124 -» Ser or Argl84 -*■ Gin, consistent with findings in B. burgdorferi (47).
The transition between the diverse thermal environments of the arthropod vector
and the human host, as well as the presentation of the verruga peruana on the extremities
(<37°C) suggests that there is a close relationship between temperature and gene expression
in B. bacilliformis. Yersinia enterocolitica DNA gyrase mutants simulate thermo-induced
alterations of DNA supercoiling with coincident phenotypic changes (45). Likewise, DNA
topology regulated by DNA gyrase may play an important role in the survival or virulence
of B. bacilliformis in both the vector and host. DNA gyrase mutants may provide a method
for analysis of thermoregulation. Furthermore, this report may contribute toward the
design of novel antibacterial and antitumor agents that target DNA topoisomerases.
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CHAPTER FIVE
General Discussion

A system for genetic manipulation greatly facilitates investigation of the poorly
understood virulence characteristics of the BartoneUa. The overall goal of this project was
to develop a system of genetic manipulation for Bartonella bacilUformis and to use this
system to satisfy molecular Koch’s postulates for the flagellum, a putative virulence factor.
First, we hypothesized that a system for genetic manipulation could be developed and
approached this hypothesis by experimenting with two separate loci of B. bacilliformis: the
gyrB gene and the fla gene.
After several initial attempts at mutagemzing wild type B.bacilliformis with suicide
plasmids, it became apparent that there were obstacles hindering in vivo homologous
recombination. This initiated an investigation into methods that alleviated restriction as well
as biochemical and metabolic manipulations that have been shown to increase the likelihood
of homologous recombination. Chapter Two summarized these strategies and discussed
the two protocol alterations that were used in combination to inactivate the fla gene by
electroporation-mediated introduction of the suicide vector pUB508.
The first, and most important, protocol alteration concerned the host strain of B .
bacilliformis used for genetic manipulation studies. Several attempts at repeating the
plasmid transformation described by Grasseschi and Minnick (61) with the cosmid pEST
produced no transformants in KC584 strain of B. bacilliformis. It was learned, however
that during these experiments (personal communication, M.F. Minnick, 1996), the cultures
were continually passaged, divergent from the low passage KC584 strain of B.
bacilliformis that we were using as a host strain. Although this protocol variation seemed
minor, with the encouragement of Dr. George Card (personal communication, Dr. George
Card, 1996), we investigated this possibility.
137
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We started with a stock of the pEST-transformed strain of B. bacilliformis extant in
the laboratory, designated HG584 (Helen Grasseschi) for this study. pEST is a replicative
plasmid that harbors the resistance cassette neomycin phosphotransferase I and confers
kanamycin resistance to HG584. Clonal subcultures of strain HG584 were passaged three
times without antibiotics. Kanamycin-sensitive clones were then verified for pEST curing
by Southern analysis and PCR. The resulting strain, PCB or ‘pEST cured Bartonella ’ was
renamed JB584. Strain JB584 demonstrated a 2000-fold increase in ‘plasmid’
transformation efficiencies with the plasmid pBBRlMCS-2 compared to KC584 and was
successfully used as the host strain for genetic site-directed manipulation studies.
To illustrate the apparently serendipitous nature of the isolation of strain JB584 (or
rather the natural mutation(s) that arose after repeated subculture by H. Grasseschi), prior
to this finding, another high passage strain of B. bacilliformis was obtained from L.
Hendrix (Texas A&M University). This strain, termed KC584-long passage, was
determined to be methylase minus based on the ability of normally non-recognizing,
non-digesting restriction enzymes to fragment chromosomal preparations. One would
expect a methyl-minus mutant to accordingly be restriction-minus, for self would be
recognized as non-self, and genomic fragmentation would result in death. Unfortunately,
the KC584-long passage strain inhibited plasmid transformation attempts similar to the
low-passage wild-type KC584. In contrast, strain JB584 is apparently methylase-positive.
The natural mutation(s) of strain JB584 that permits high transformation efficiencies
is still unknown. Based on numerous unsuccessful attempts of genetic manipulation using
linear gene targeting constructs with both the fla and gyrB loci, we believe there is still a
powerful exonuclease activity in JB584. High passaged strains of B. henselae, for
example, have shown a reduction in in vitro pathogenicity (13). Thus, the integrity of
JB584 must be questioned in this light, for it is also a high passage strain. Considering the
adhesion data generated in Chapter Three of this work, JB584 does not seem to have a
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reduction in adhesion when compared to the low-passaged wild-type strain KC584.
However, virulent clinical isolates of B. bacilliformis have not been compared to KC584 in
in vitro pathogenicity assays. Much can be learned from the utilization of the
transformation-competent strain JB584, but effects of passage cannot be realized until
further virulence analyses are done. One interesting use for JB584 is as a DNA modifying
strain. Considering the methylase positive phenotype, coupled with strain transformation
competency, plasmids could conceivably be introduced into JB584, methylated, purified,
and subsequently introduced into a virulent clinical isolate strain. In conclusion, we
hypothesize that the high transformation efficiencies associated with strain JB584 are a
result of a restriction endonuclease mutation. Several attempts to clone and characterize the
methylase-restriction enzymes of B. bacilliformis using a blue-white isolation system
proved unsuccessful.
The second protocol alteration that may have influenced the efficiencies of
homologous recombination was the addition of low levels of methionine to the recovery
broth. Since strain JB584 apparently did not fragment foreign supercoiled plasmids, we
hypothesized that we could encourage the in vivo conditions required for homologous
recombination to occur. This hypothesis was based on increasing the in vivo levels of
RecA. Although RecA-independent homologous recombination has been demonstrated
(16), RecA is considered the mediator of most prokaryotic homologous recombination.
Growth in the presence of methionine has been shown to decrease the levels of
S-adenosylmethionine (SAM) in vivo (78, 165). SAM is the methyl donor for
DNA-methylases and is also required for the function of Type I restriction enzymes (17).
We hypothesized that in the presence of methionine a reduction in SAM levels would
inhibit normal methylation of DNA in vivo. Directly, this should create a confusion
between self and non-self DNA allowing foreign DNA, such as a suicide plasmid, to
survive long enough to find its target and cross over. Indirectly, a confusion over self and
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non-self would hypothetically induce self-restriction and thus, the generation of single
stranded DNA. Single-stranded DNA is the signal for SOS induction, and induction of
SOS results in an increase in RecA. Thus, we hypothesize that methionine is inhibiting
DNA methylation, which distorts self vs. non-self recognition and results in single
stranded DNA, inducing SOS and finally resulting in an increase in RecA. Furthermore,
since UV light-induced SOS induction has been correlated with temporary alleviation of
host-controlled restriction in Cyanobacterium, Bacillus, and E. coli (47, 74, 75, 178,
187), it follows that a non-mutagenic method of SOS induction should decrease restriction.
The presence of methionine does not seem to have an effect on rates of plasmid
transformation, but in light of the benign enhancements to homologous recombination, we
have left this supplement in our protocol. The efficacy of methionine as a nonspecific,
non-mutational (ie. UV-light) SOS inducer to enhance homologous recombination is
unknown.
With the two protocol modifications of JB584 and methionine we were able to
construct a fla -minus mutant of B. bacilliformis. This was accomplished by site-directed
mutagenesis using the suicide vector, pUB508. The Jla- mutant [JB585] was unable to
synthesize flagellin, and a motility assay demonstrated that the mutant was non-motile. We
then complemented this jla -minus mutant by introducing the wild type jla ORF on the
shuttle plasmid pBBRFLAG. The complemented mutant was able to express, assemble,
and secrete flagellin subunits resulting in a motility phenotype that was indistinguishable
from wild-type. Finally, the strains were assessed for their ability to adhere to human
erythrocytes. The jla mutant demonstrated a significant loss in its ability to adhere,
whereas the complemented mutant showed a partial restoration of its ability to adhere to
human erythrocytes.
Pathogenicity is defined as the ability of an organism to cause disease. The tools or
mechanisms that the organism uses to cause disease are defined as the virulence factors.
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These virulence factors, or virulence determinants, are best studied by the satisfaction of a
molecular set of Koch’s postulates (49). In 1875 Robert Koch established a set of
experiments, now termed Koch’s postulates, which enabled him to prove that a germ.
Bacillus anthracis, was the causative agent of the disease anthrax. With these experiments,
Koch verified the germ theory of disease. In 1926 Noguchi and Battistini demonstrated
Koch’s postulates with B. bacilliform is in macaque monkeys (180). To date, many
infectious agents have been discovered as the cause of disease by verifying Koch’s
postulates. Recently, molecular Koch’s postulates was proposed by Falkow (49) as a
precise means of determining the relationship between a putative virulence factor and the
pathogenesis of an organism. These postulates are mentioned in Chapter Three. By
demonstrating the significant reduction in the ability of the fla -minus mutant to adhere to
human erythrocytes, combined with the partial restoration of adherence phenotype
expressed by the complemented strain, we have at least partially demonstrated molecular
Koch’s postulates for the B. bacilliform is flagellum. This is the First demonstration of
molecular Koch’s postulates for any Bartonella as well as the First demonstration of
site-specific mutagenesis and complementation for the Bartonella.
The mechanism by which Bartonella gain entry into erythrocytes is unknown. The
working model of B. bacilliform is erythrocyte invasion is termed ‘forced endocytosis’, in
which the organism uses several virulence mechanisms to adhere and subsequently gain
entry into the erythrocyte (119). Initial interaction and adhesion with the erythrocyte
surface may be influenced by the flagella (164), filament A (121), or BFP (114).
Subsequently, the activity of three virulence factors, IalA/IalB (132), deformin (116,189),
and the flagella (14, 164) may work together to coordinate erythrocyte invasion. Our study
concerning the flagella-mediated erythrocyte adhesion supports this model of ‘forced
endocytosis’.
The system of genetic manipulation developed herein will provide the genetic tools
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to decipher much more about the pathogenesis of Bartonella. One example of this is the
recent demonstration of site-specific mutagenesis of the ialB locus (personal
communication, S. Coleman, 1998). Another example is the research currently being
conducted in our laboratory concerning genetic exchange by the bacteriophage-like-particle
(BLP) associated with B. bacilliform is (personal communication K. Barbian and M.F.
Minnick). As mentioned in chapter one, this phage packages random 14-kbp fragments of
chromosomal DNA. By purifying the BLP’s associated with insertional mutants of B .
bacilliformis, one can study transduction based on the ability of these particles to deliver
resistance cassettes. Finally, a strain of B. bacilliform is has been constructed that is
expressing the green fluorescent protein (GFP)( 176) from the B. bacilliform is fla
promoter. This strain can be used for numerous applications including in vivo localization
in both host and vector, as well as for studies on regulation of flagellin expression.

We believe that this system of genetic manipulation will contribute significantly to the
understanding of the molecular biology and pathogenesis of Bartonella.
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